6-K

Brookfield Wealth Solutions Ltd. (BNT)

6-K 2025-05-13 For: 2025-03-31
View Original
Added on April 08, 2026

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF

BROOKFIELD WEALTH SOLUTIONS LTD.

AS OF MARCH 31, 2025 AND DECEMBER 31, 2024

AND FOR THE THREE MONTHS ENDED

MARCH 31, 2025 AND 2024

INDEX

Page
Unaudited Condensed Consolidated Statements of Financial Position 1
Unaudited Condensed Consolidated Statements of Operations 2
Unaudited Condensed Consolidated Statements of Comprehensive Income 3
Unaudited Condensed Consolidated Statements of Changes in Equity 4
Unaudited Condensed Consolidated Statements of Cash Flows 5
Notes to the Unaudited Condensed Consolidated Financial Statements 7
Management’s Discussion and Analysis of Financial Condition and Results of Operations 62

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

AS OF US MILLIONS, EXCEPT SHARE DATA March 31, 2025 December 31, 2024
Assets
Available-for-sale fixed maturity securities, at fair value (net of allowance for credit losses of 12 and 27, respectively; amortized cost of 55,118 and 53,651, respectively) $ 55,759 $ 53,802
Equity securities, at fair value 3,468 3,854
Mortgage loans on real estate, at amortized cost (net of allowance for credit losses of 168 and 158, respectively) 11,901 12,426
Private loans, at amortized cost (net of allowance for credit losses of 105 and 97, respectively) 5,600 5,204
Investment real estate, at cost (net of accumulated depreciation of 231 and 232, respectively) 2,388 2,366
Real estate partnerships 3,458 3,438
Investment funds 6,235 6,111
Policy loans 265 276
Short-term investments, at estimated fair value 8,425 4,400
Other invested assets 1,110 1,089
Total investments 98,609 92,966
Cash and cash equivalents 8,261 12,243
Accrued investment income 841 860
Deferred policy acquisition costs, deferred sales inducements and value of business acquired 10,848 10,696
Reinsurance funds withheld 1,492 1,517
Premiums due and other receivables 677 647
Ceded unearned premiums 488 520
Deferred tax asset 777 760
Reinsurance recoverables and deposit assets 12,957 13,195
Property and equipment (net of accumulated depreciation of 389 and 377, respectively) 269 272
Intangible assets (net of accumulated amortization of 143 and 106, respectively) 1,705 1,690
Goodwill 783 783
Other assets 2,652 2,461
Separate account assets 1,253 1,343
Total assets 141,612 139,953
Liabilities
Future policy benefits 14,582 14,088
Policyholders’ account balances 84,606 83,079
Policy and contract claims 7,588 7,659
Deposit liabilities 1,483 1,502
Market risk benefits 4,066 3,655
Unearned premium reserve 1,674 1,843
Due to related parties 692 684
Other policyholder funds 357 347
Notes payable 196 189
Corporate borrowings 1,004 1,022
Subsidiary borrowings 3,332 3,329
Funds withheld for reinsurance liabilities 3,266 3,392
Other liabilities 4,503 4,745
Separate account liabilities 1,253 1,343
Total liabilities 128,602 126,877
Equity
Class A exchangeable and Class B (33.01 and 33.10 par value, respectively; 43,473,884 and 43,460,516 issued, respectively; 41,395,860 and 41,460,516 outstanding, respectively)(1) 1,437 1,442
Class C (1 par value; 201,116,647 and 201,116,647 issued and outstanding, respectively) 8,526 8,526
Retained earnings 1,728 2,054
Accumulated other comprehensive income 548 204
Non-controlling interests 771 850
Total equity 13,010 13,076
Total liabilities and equity $ 141,612 $ 139,953

All values are in US Dollars.

__________________________

(1)2,078,024 Class A exchangeable shares were held in treasury as of March 31, 2025 (December 31, 2024 – 2,000,000 Class A exchangeable shares).

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Page 1

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS Note 2025 2024
Net premiums 12 $ 1,122 $ 1,531
Other policy revenue 12 179 112
Net investment income 10 1,413 574
Investment related gains (losses) 10 (103) 44
Net investment results from reinsurance funds withheld 7 224
Total revenues 2,618 2,485
Policyholder benefits and claims incurred 12, 17, 20 (1,107) (1,414)
Interest sensitive contract benefits 12, 18 (524) (185)
Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired 14 (339) (225)
Change in fair value of insurance-related derivatives and embedded derivatives 9 (200) 44
Change in fair value of market risk benefits 12, 19 (361) (31)
Other reinsurance expenses (1) (7)
Operating expenses (382) (233)
Interest expense (73) (72)
Total benefits and expenses (2,987) (2,123)
Net income (loss) before income taxes (369) 362
Income tax recovery (expense) 22 87 (25)
Net income (loss) $ (282) $ 337
Attributable to:
Class A exchangeable and Class B shareholders(1) $ 4 $ 3
Class C shareholders (330) 332
Non-controlling interests 44 2
$ (282) $ 337
Net income (loss) per Class C share:
Basic 25 $ (1.64) $ 2.98

__________________________

(1)On August 29, 2024, the Company redesignated all of its Class A-1 exchangeable shares into its Class A exchangeable shares. Amounts attributable to Class A exchangeable and Class B shareholders include amounts attributable to Class A-1 exchangeable shareholders prior to the redesignation.

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Page 2

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS Note 2025 2024
Net income (loss) $ (282) $ 337
Other comprehensive income (loss), net of tax:
Change in net unrealized investment gains (losses) 318 (106)
Foreign currency translation 38 (14)
Change in discount rate for future policy benefits 17 (58) 159
Change in instrument-specific credit risk for market risk benefits 19 49 (38)
Defined benefit pension plan adjustment (3) 3
Total other comprehensive income 24 344 4
Comprehensive income $ 62 $ 341 Attributable to:
--- --- --- --- ---
Class A exchangeable and Class B shareholders(1) $ 4 $ 3
Class C shareholders 14 336
Non-controlling interests 44 2
$ 62 $ 341

__________________________

(1)On August 29, 2024, the Company redesignated all of its Class A-1 exchangeable shares into its Class A exchangeable shares. Amounts attributable to Class A exchangeable and Class B shareholders include amounts attributable to Class A-1 exchangeable shareholders prior to the redesignation.

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Page 3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

Class A exchangeable and Class B shareholders Class C shareholders
FOR THE THREE MONTHS ENDED MAR. 31, 2025<br>US$ MILLIONS Share<br>capital Retained earnings Total Share<br>capital Retained earnings Accumulated other comprehensive income Total Non-controlling interests Total<br>equity
Balance as of January 1, 2025 $ 1,442 $ 28 $ 1,470 $ 8,526 $ 2,026 $ 204 $ 10,756 $ 850 $ 13,076
Net income (loss) 4 4 (330) (330) 44 (282)
Other comprehensive income 344 344 344
Comprehensive income 4 4 (330) 344 14 44 62
Other items:
Equity issuances, net (90) (90)
Distributions(1) (4) (4) (33) (37)
Acquisition of treasury shares, net (1) (1) (1)
Total change in the period (5) 4 (1) (330) 344 14 (79) (66)
Balance as of March 31, 2025 $ 1,437 $ 32 $ 1,469 $ 8,526 $ 1,696 $ 548 $ 10,770 $ 771 $ 13,010

__________________________

(1)The Company distributed $0.09 in the form of a return of capital per each Class A exchangeable and Class B share in the first quarter of 2025.

Class A exchangeable, Class A-1 exchangeable and Class B shareholders Class C shareholders
FOR THE THREE MONTHS ENDED MAR. 31, 2024<br>US$ MILLIONS Share<br>capital Retained<br>earnings Total Share<br>capital Retained<br>earnings Accumulated other comprehensive income (loss) Total Non-controlling interests Total <br>equity
Balance as of January 1, 2024 $ 1,577 $ 14 $ 1,591 $ 3,607 $ 931 $ (120) $ 4,418 $ 146 $ 6,155
Net income 3 3 332 332 2 337
Other comprehensive income 4 4 4
Comprehensive income 3 3 332 4 336 2 341
Other items:
Distributions and redeemable preferred share dividends(1) (3) (3) (28) (28) (3) (34)
Total change in the period (3) 3 304 4 308 (1) 307
Balance as of March 31, 2024 $ 1,574 $ 17 $ 1,591 $ 3,607 $ 1,235 $ (116) $ 4,726 $ 145 $ 6,462

__________________________

(1)The Company distributed $0.08 in the form of a return of capital per each Class A exchangeable, Class A-1 exchangeable and Class B share in the first quarter of 2024.

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Page 4

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Operating activities
Net income (loss) $ (282) $ 337
Adjustments to reconcile net income to net cash from operating activities:
Other policy revenue (179) (112)
Accretion on investments (223) (196)
Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired 339 225
Deferral of policy acquisition costs (349) (233)
Losses (gains) on investments and derivatives 484 (146)
Provisions for credit losses (1) 1
Income from real estate partnerships, investment funds and corporations (163) (55)
Distributions from real estate partnerships, investment funds and corporations 159 61
Interest credited to policyholders’ account balances 512 155
Change in fair value of embedded derivatives (124) (79)
Depreciation and amortization 64 36
Deferred income taxes (90) 15
Changes in operating assets and liabilities:
Insurance-related liabilities 482 437
Deposit liabilities (48) (46)
Funds withheld under reinsurance (70) (35)
Reinsurance recoverables and deposit assets 350 (32)
Accrued investment income (10) (43)
Working capital and other (322) (58)
Cash flows from operating activities 529 232
Investing activities
Purchase of investments:
Fixed maturity, available-for-sale (3,192) (1,989)
Equity securities (43) (11)
Mortgage loans on real estate (290) (130)
Private loans (635) (222)
Investment real estate and real estate partnerships (68) (20)
Investment funds (151) (151)
Short-term investments (7,861) (6,788)
Other invested assets (21) (41)
Proceeds from sales and maturities of investments:
Fixed maturity, available-for-sale 2,050 1,112
Equity securities 195 4
Mortgage loans on real estate 857 113
Private loans 187 18
Investment real estate and real estate partnerships 41 114
Investment funds 35 67
Short-term investments 3,803 5,660
Other invested assets 18 4
Purchase of derivatives (213) (49)
Proceeds from sales and maturities of derivatives 299 (7)
Purchase of intangibles and property and equipment (7) (16)
Change in collateral held for derivatives (575) 88
Other 2 (49)
Cash flows from investing activities (5,569) (2,293)

Page 5

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Financing activities
Return of capital to common stockholders (4) (3)
Borrowings from related parties 188
Repayment of borrowings to related parties (5) (188)
Borrowings from external parties 527 345
Repayment of borrowings to external parties (545) (369)
Repayment of borrowings issued to reinsurance entities (6)
Policyholders’ account deposits 3,514 992
Policyholders’ account withdrawals (2,301) (662)
Debt issuance costs 1
Proceeds from repurchase agreement 26 40
Repayments of repurchase agreement (26) (7)
Issuance (redemption) of capital with non-controlling interests, net (94)
Distributions to non-controlling interests (33) (3)
Cash flows from financing activities 1,054 333
Cash and cash equivalents
Cash and cash equivalents, beginning of period 12,243 4,308
Net change during the period (3,986) (1,728)
Foreign exchange on cash balances held in foreign currencies 4 (6)
Cash and cash equivalents, end of period $ 8,261 $ 2,574
Supplementary cash flow disclosures
Cash taxes paid (net of refunds received) $ (23) $ 6
Cash interest paid 48 59
Non-cash transactions:
Investments received in connection with pension risk transfer transactions 462

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

Page 6

NOTE 1. NATURE OF OPERATIONS

Brookfield Wealth Solutions Ltd. (“Brookfield Wealth Solutions”) is a Bermuda corporation incorporated on December 10, 2020 and governed by the laws of Bermuda. References in these financial statements to “we”, “our”, “us” or “the Company” refer to Brookfield Wealth Solutions and its subsidiaries, whereas references to “Brookfield” refer to Brookfield Corporation and its subsidiaries. The Company’s class A exchangeable shares are listed on the New York Stock Exchange (“NYSE”) and the Toronto Stock Exchange (“TSX”) under the symbol “BNT”. Our operations are located primarily in Bermuda, the United States (“U.S.”), Canada, the Cayman Islands and the United Kingdom (“U.K.”). The Company’s registered head office address is Ideation House, First Floor, 94 Pitts Bay Road, Pembroke, HM08, Bermuda.

Our company is focused on securing the financial futures of individuals and institutions through a range of retirement services, wealth protection products and tailored capital solutions. Through our direct 100% ownership interest in BAM Re Holdings Ltd. (“BAM Re Holdings”), we hold the interest in our operating subsidiaries, which are: American National Group Inc. (“ANGI”), Argo Group International Holdings, Inc. (“Argo”), Blumont Annuity Company (“BAC Canada”), Blumont Annuity Company UK Ltd. (“BAC UK”), North End Re Ltd. (“NER Ltd.”) and North End Re (Cayman) SPC (“NER SPC”).

As a result of the Company’s acquisition of American Equity Investment Life Holdings Company (“AEL”) in May 2024, diversification in insurance offerings and overall strategic shift, the Company reorganized and changed its internal segments in a manner that caused the composition of its reporting segments to change in the second quarter of 2024. The Company’s reporting segments were realigned to Annuities, Property and Casualty (“P&C”), Life Insurance and Corporate and Other. Previously, the Company reported its operations under three segments: Direct Insurance, Reinsurance and Pension Risk Transfer (“PRT”). For segment information, refer to Note 27. The Company has restated all applicable comparative information.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The unaudited condensed consolidated financial statements (“financial statements”) and notes thereto, including all prior periods presented, have been prepared under accounting principles generally accepted in the United States of America (“GAAP”). The financial statements are prepared on a going concern basis and have been presented in U.S. dollars (“USD”) rounded to the nearest million unless otherwise indicated. The financial statements should be read in conjunction with the December 31, 2024 audited consolidated financial statements of the Company and accompanying notes and financial statement schedules included on the Form 20-F, filed with the SEC on March 27, 2025. The results of operations for the three months ended March 31, 2025 are not necessarily indicative of the results for any subsequent period or the entire fiscal year ending December 31, 2025. These financial statements reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of results for the interim periods presented in accordance with GAAP.

The preparation of the financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Included among the material (or potentially material) reported amounts and disclosures that require use of estimates are fair value of certain financial assets, derivatives, allowances for credit losses, deferred policy acquisition costs (“DAC”), value of business acquired (“VOBA”), reinsurance funds withheld, goodwill and other intangibles, market risk benefits (“MRB”), future policy benefits (“FPB”), policyholders’ account balances (“PAB”) including the fair value of embedded derivatives, policy and contract claims, income taxes including the recoverability of deferred tax assets, and the potential effects of resolving litigated matters. Such estimates and assumptions are subject to inherent uncertainties, which may result in actual amounts differing from reported amounts.

Basis of Consolidation

These financial statements include the accounts of the Company and its consolidated subsidiaries, which are legal entities where the Company has a controlling financial interest either by holding a majority voting interest or as the primary beneficiary of the variable interest entity (“VIE”). All intra-group transactions, balances, income and expenses are eliminated in full on consolidation.

Page 7

The consolidation assessment depends on the specific facts and circumstances for each entity and requires judgment. Refer to Note 2 of the Company’s December 31, 2024 audited consolidated financial statements for a further description of the Company’s accounting policies regarding consolidation.

Adoption of New Accounting Standards

In the current period, the Company did not adopt any Accounting Standard Update (“ASU”) issued by the Financial Accounting Standards Board (“FASB”) that were material in presentation or amount.

Recently issued accounting pronouncements

The Company continues to assess the impacts of the following ASUs issued but not yet adopted as of March 31, 2025 on the financial statements. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.

ASU 2023-09 – On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this ASU aim to enhance the transparency and decision-usefulness of income tax disclosures, particularly in the rate reconciliation table and disclosures about income taxes paid. Among other things, it requires, on an annual basis, the disclosure of the following: (i) specific categories in the rate reconciliation; (ii) additional information for reconciling items that meet a quantitative threshold; (iii) the amount of income taxes paid disaggregated by federal, state, and foreign taxes; and (iv) the amount of income taxes paid disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5 percent of total income taxes paid. This ASU will be effective for annual reporting periods beginning after December 15, 2024 to be applied prospectively with an option for retrospective application, with early adoption permitted. We do not expect the adoption of this ASU to have a material impact on our financial statements.

ASU 2024-03 – On November 4, 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this ASU require public business entities to disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. This ASU will be effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, to be applied on either a retrospective or prospective basis subject to certain exceptions, with early adoption permitted. We are currently evaluating the impact of this ASU on our financial statements. However, as they apply to disclosure requirements, the adoption of this ASU is not anticipated to have a material impact on our profitability, financial position or cash flows.

NOTE 3. AVAILABLE-FOR-SALE FIXED MATURITY SECURITIES

The amortized cost and fair value of available-for-sale fixed maturity securities are shown below:

AS OF MAR. 31, 2025<br>US$ MILLIONS Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value
U.S. treasury and government $ 403 $ 3 $ (42) $ $ 364
U.S. state and municipal 3,216 90 (24) 3,282
Foreign governments 1,646 27 (22) 1,651
Corporate debt securities 37,546 779 (338) (10) 37,977
Residential mortgage-backed securities 1,189 43 (3) (1) 1,228
Commercial mortgage-backed securities 3,386 116 (33) 3,469
Collateralized debt securities 7,732 134 (77) (1) 7,788
Total fixed maturity securities $ 55,118 $ 1,192 $ (539) $ (12) $ 55,759

Page 8

AS OF DEC. 31, 2024<br>US$ MILLIONS Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Allowance for Credit Losses Fair Value
U.S. treasury and government $ 410 $ 2 $ (43) $ $ 369
U.S. state and municipal 3,280 39 (30) 3,289
Foreign governments 2,082 11 (51) 2,042
Corporate debt securities 37,312 571 (477) (26) 37,380
Residential mortgage-backed securities 1,288 28 (5) (1) 1,310
Commercial mortgage-backed securities 3,259 91 (30) 3,320
Collateralized debt securities 6,020 103 (31) 6,092
Total fixed maturity securities $ 53,651 $ 845 $ (667) $ (27) $ 53,802

The amortized cost and fair value, by contractual maturity, of available-for-sale fixed maturity securities are shown below. Actual maturities may differ from contractual maturities as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Residential and commercial mortgage-backed securities and collateralized debt securities, which are not due at a single maturity, have been separately presented below.

AS OF MAR. 31, 2025<br>US$ MILLIONS Amortized Cost Fair Value
Due in one year or less $ 1,846 $ 1,853
Due after one year through five years 15,815 16,006
Due after five years through ten years 6,913 7,034
Due after ten years 18,237 18,381
42,811 43,274
Residential mortgage-backed securities 1,189 1,228
Commercial mortgage-backed securities 3,386 3,469
Collateralized debt securities 7,732 7,788
Total $ 55,118 $ 55,759

Proceeds from sales of available-for-sale fixed maturity securities, with the related gross realized gains and losses, are shown below:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Proceeds from sales of available-for-sale fixed maturity securities $ 2,050 $ 1,112
Gross realized gains 6 15
Gross realized losses (3) (6)

The Company has pledged bonds in connection with certain agreements and transactions, such as financing and reinsurance agreements. The carrying value of bonds pledged was $7.4 billion and $8.9 billion as of March 31, 2025 and December 31, 2024, respectively.

In accordance with various regulations, the Company has securities on deposit with regulating authorities with a carrying value of $195 million and $213 million as of March 31, 2025 and December 31, 2024, respectively. There are no restrictions on these assets.

Page 9

The gross unrealized losses and fair value of available-for-sale fixed maturity securities, aggregated by investment category and the length of time individual securities have been in a continuous unrealized loss position due to market factors are shown below:

Less than 12 months 12 months or more Total
AS OF MAR. 31, 2025<br>US$ MILLIONS, EXCEPT NUMBER OF ISSUES Number of Issues Gross Unrealized Losses Fair Value Number of Issues Gross Unrealized Losses Fair Value Number of Issues Gross Unrealized Losses Fair Value
U.S. treasury and government 4 $ (7) $ 29 19 $ (35) $ 87 23 $ (42) $ 116
U.S. state and municipal 75 (14) 294 152 (10) 252 227 (24) 546
Foreign governments 12 (7) 405 26 (15) 65 38 (22) 470
Corporate debt securities 1,099 (131) 5,871 522 (207) 4,329 1,621 (338) 10,200
Residential mortgage-backed securities 32 (2) 146 5 (1) 15 37 (3) 161
Commercial mortgage-backed securities 103 (28) 674 11 (5) 64 114 (33) 738
Collateralized debt securities 206 (47) 1,353 16 (30) 422 222 (77) 1,775
Total 1,531 $ (236) $ 8,772 751 $ (303) $ 5,234 2,282 $ (539) $ 14,006 Less than 12 months 12 months or more Total
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
AS OF DEC. 31, 2024<br>US$ MILLIONS, EXCEPT NUMBER OF ISSUES Number of Issues Gross Unrealized Losses Fair Value Number of Issues Gross Unrealized Losses Fair Value Number of Issues Gross Unrealized Losses Fair Value
U.S. treasury and government 6 $ (7) $ 54 19 $ (36) $ 87 25 $ (43) $ 141
U.S. state and municipal 174 (20) 851 190 (10) 280 364 (30) 1,131
Foreign governments 30 (38) 1,520 28 (13) 49 58 (51) 1,569
Corporate debt securities 1,669 (172) 7,199 590 (305) 4,949 2,259 (477) 12,148
Residential mortgage-backed securities 95 (4) 227 16 (1) 61 111 (5) 288
Commercial mortgage-backed securities 104 (25) 667 9 (5) 27 113 (30) 694
Collateralized debt securities 179 (29) 1,182 15 (2) 35 194 (31) 1,217
Total 2,257 $ (295) $ 11,700 867 $ (372) $ 5,488 3,124 $ (667) $ 17,188

The unrealized losses as of March 31, 2025 and December 31, 2024 are principally related to the timing of the purchases of certain securities, which carry less yield than those available as of those dates. Approximately 93% and 89% of the fair value of fixed maturity securities shown above as of March 31, 2025 and December 31, 2024, respectively, are rated investment grade.

The Company expects to recover the amortized cost on all securities except for those securities on which it recognized an allowance for credit loss. In addition, as the Company did not have the intent to sell fixed maturity securities with unrealized losses and it was not more likely than not that the Company would be required to sell these securities prior to recovery of the amortized cost, which may be maturity, the Company did not write down these investments to fair value through the statements of operations.

Page 10

Allowance for Credit Losses

Several assumptions and underlying estimates are made in the evaluation of allowance for credit loss. Examples include financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry conditions and trends and implications of rating agency actions and offering prices. Based on this evaluation, unrealized losses on available-for-sale securities where an allowance for credit loss was not recorded were concentrated within the financials sector as of March 31, 2025 and December 31, 2024.

The rollforward of the allowance for credit losses for available-for-sale fixed maturity securities is shown below for the three months ended March 31, 2025 and 2024.

FOR THE PERIOD ENDED MAR. 31, 2025<br>US$ MILLIONS Corporate Debt Securities Residential Mortgage Backed Securities Commercial Mortgage Backed Securities Collateralized Debt Securities Total
Balance as of Jan. 1, 2025 $ (26) $ (1) $ $ $ (27)
Credit losses recognized on securities for which credit losses were not previously recorded (7) (1) (8)
Reductions for securities sold during the period 15 15
Changes in previously recorded allowance 8 8
Balance as of Mar. 31, 2025 $ (10) $ (1) $ $ (1) $ (12) FOR THE PERIOD ENDED MAR. 31, 2024<br>US$ MILLIONS Corporate Debt Securities Residential Mortgage Backed Securities Commercial Mortgage Backed Securities Collateralized Debt Securities Total
--- --- --- --- --- --- --- --- --- --- ---
Balance as of Jan. 1, 2024 $ (19) $ (1) $ (6) $ (4) $ (30)
Credit losses recognized on securities for which credit losses were not previously recorded (12) (12)
Reductions for securities sold during the period 1 1
Changes in previously recorded allowance 6 1 2 9
Balance as of Mar. 31, 2024 $ (24) $ $ (6) $ (2) $ (32)

No accrued interest receivables were written off as of March 31, 2025 and December 31, 2024.

Page 11

NOTE 4. EQUITY SECURITIES

The net gains (losses) on equity securities recognized in “Investment related gains (losses)” on the statements of operations are shown below:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Unrealized gains (losses) on equity securities $ (260) $ 20
Net gains (losses) on equity securities sold 78
Net gains (losses) on equity securities $ (182) $ 20

Equity securities by market sector distribution are shown below, based on carrying value:

AS OF March 31, 2025 December 31, 2024
Consumer goods 3 % 5 %
Education 8 % 7 %
Energy and utilities 6 % 5 %
Finance 62 % 62 %
Healthcare 1 % 3 %
Industrials 9 % 7 %
Information technology 11 % 10 %
Other % 1 %
Total 100 % 100 %

NOTE 5. MORTGAGE LOANS ON REAL ESTATE

The Company disaggregates its mortgage loan investments into two portfolio segments: commercial and residential. Commercial mortgage loans include agricultural mortgage loans. The breakdown of mortgage loans on real estate by portfolio segment is as follows:

AS OF <br>US$ MILLIONS March 31, 2025 December 31, 2024
Commercial mortgage loans $ 9,417 $ 9,891
Residential mortgage loans 2,652 2,693
Total 12,069 12,584
Allowance for credit losses (168) (158)
Total, net of allowance $ 11,901 $ 12,426

Page 12

The Company’s commercial mortgage loan portfolio consists of loans collateralized by the related properties and diversified as to property type, location and loan size. The geographic categories come from the U.S. Census Bureau’s “Census Regions and Divisions of the United States”. The commercial mortgage loan portfolio is summarized by geographic region and property type as follows:

AS OFUS MILLIONS, EXCEPT FOR PERCENTAGES March 31, 2025 December 31, 2024
Percentage Amount Percentage
Geographic distribution:
Pacific $ 2,072 22 % $ 2,126 21 %
Mountain 1,637 17 % 1,687 17 %
West North Central 307 3 % 302 3 %
West South Central 1,419 15 % 1,480 15 %
East North Central 993 11 % 1,084 11 %
East South Central 139 1 % 146 1 %
Middle Atlantic 661 7 % 677 7 %
South Atlantic 1,815 20 % 2,029 21 %
New England 155 2 % 149 2 %
Other (multi-region, non-US) 219 2 % 211 2 %
Total $ 9,417 100 % $ 9,891 100 %
Allowance for Credit losses (158) (149)
Total, net of allowance $ 9,259 $ 9,742
AS OFUS MILLIONS, EXCEPT FOR PERCENTAGES March 31, 2025 December 31, 2024
Percentage Amount Percentage
Property type distribution:
Agricultural $ 446 5 % $ 447 5 %
Apartment 2,457 26 % 2,533 25 %
Hotel 1,192 13 % 1,251 13 %
Industrial 1,679 18 % 1,930 20 %
Office 1,381 14 % 1,418 13 %
Parking 287 3 % 297 3 %
Retail 1,600 17 % 1,633 17 %
Storage 159 2 % 181 2 %
Other 216 2 % 201 2 %
Total $ 9,417 100 % $ 9,891 100 %
Allowance for Credit losses (158) (149)
Total, net of allowance $ 9,259 $ 9,742

All values are in US Dollars.

There was no interest income recognized on loans in non-accrual status for the three months ended March 31, 2025 and 2024. Impaired loans were not significant for any of the periods presented.

Page 13

Allowance for Credit Losses

The Company establishes a valuation allowance to provide for the risk of credit losses inherent in its mortgage loan portfolios. The valuation allowance is maintained at a level believed adequate by management to absorb estimated expected credit losses. The valuation allowance is based on amortized cost, which excludes accrued interest receivable. The Company does not measure a credit loss allowance on accrued interest receivable, and any uncollectible accrued interest receivable balances are written off to net investment income in a timely manner. The Company did not write off any uncollectible accrued interest receivable on its commercial or residential mortgage loan portfolios for the three months ended March 31, 2025 and 2024, respectively. The rollforward of the allowance for credit losses for mortgage loans is shown below:

2025 2024
FOR THE PERIODS ENDED MAR. 31<br>US$ MILLIONS Commercial mortgage loans Residential mortgage loans Commercial mortgage loans Residential mortgage loans
Balance, as of January 1 $ (149) $ (9) $ (60) $
Provision (12) (1) (1)
Writeoffs charged against the allowance 3
Balance, as of March 31 $ (158) $ (10) $ (61) $

Credit Quality Indicators

Mortgage loans are segregated by property-type and quantitative and qualitative allowance factors are applied. Qualitative factors are developed quarterly based on the pooling of assets with similar risk characteristics and historical loss experience adjusted for the expected trend in the current market environment. Credit losses are pooled by property type as it represents the most similar and reliable risk characteristics in our portfolio. The amortized cost of mortgage loans by year of origination by aging category are shown below:

AS OF MAR. 31, 2025US MILLIONS Amortized Cost Basis by Origination Year
2024 2023 2022 2021 Prior Total
Commercial mortgage loans:
Current $ 27 $ 410 $ 570 $ 2,218 $ 1,301 $ 4,411 $ 8,937
30-59 days past due 82 84 5 112 283
60-89 days past due 4 40 44
Non-accrual 8 48 52 45 153
Residential mortgage loans:
Current 102 337 707 945 218 133 2,442
30-59 days past due 1 12 26 1 3 43
60-89 days past due 1 1
Non-accrual 3 67 73 16 7 166
Total mortgage loans on real estate $ 129 $ 833 $ 1,368 $ 3,395 $ 1,593 $ 4,751 $ 12,069
Allowance for credit losses (168)
Total, net of allowance $ 11,901

All values are in US Dollars.

Page 14

AS OF DEC. 31, 2024US MILLIONS Amortized Cost Basis by Origination Year
2023 2022 2021 2020 Prior Total
Commercial mortgage loans:
Current $ 569 $ 607 $ 2,428 $ 1,280 $ 961 $ 3,735 $ 9,580
30-59 days past due 25 4 10 48 87
60-89 days past due 50 30 80
Non-accrual 8 42 40 6 48 144
Residential mortgage loans:
Current 291 790 970 222 121 7 2,401
30-59 days past due 3 41 45 2 4 95
60-89 days past due 7 20 2 4 5 38
Non-accrual 3 51 76 18 8 3 159
Total mortgage loans on real estate $ 866 $ 1,529 $ 3,635 $ 1,594 $ 1,114 $ 3,846 $ 12,584
Allowance for credit losses (158)
Total, net of allowance $ 12,426

All values are in US Dollars.

Generally, mortgage loans are secured by first liens on income-producing real estate with a loan-to-value ratio of up to 75%. It is the Company’s policy to not accrue interest on loans that are 90 days delinquent and where amounts are determined to be uncollectible. As of March 31, 2025, 307 mortgage loans were past due over 90 days or in non-accrual status (December 31, 2024 – 266 mortgage loans).

The Company’s commercial and residential mortgage loans may be subject to loan modifications. Loan modifications may be granted to borrowers experiencing financial difficulty and could include principal forgiveness, interest rate reduction, an other-than-significant delay or a term extension. A loan modification typically does not result in a change in valuation allowance as it is already incorporated into the Company’s allowance methodology. However, if the Company grants a borrower experiencing financial difficulty principal forgiveness, the amount of principal forgiven would be written off, which would reduce the amortized cost of the loan and result in an adjustment to the valuation allowance. The carrying amount of mortgage loans experiencing financial difficulty, for which modifications have been granted, was $29 million and nil for the three months ended March 31, 2025 and 2024, respectively.

Page 15

NOTE 6. PRIVATE LOANS

The following table summarizes the credit ratings of our private loans:

AS OF <br>US$ MILLIONS March 31, 2025 December 31, 2024
A or higher $ 1,594 $ 1,595
BBB 796 692
BB and below 1,648 875
Unrated(1) 1,562 2,042
Total $ 5,600 $ 5,204

__________________________

(1)Due to the nature of private loans, external agency credit ratings may not be readily available. Where appropriate, the Company obtains non-published credit ratings from one or more third-party rating agencies, which are determined based on an independent evaluation of the transaction. For other loans without published or private credit ratings, the Company assigns internal risk ratings, based on its investment selection and monitoring process and policies. These internal risk ratings are categorized as “Unrated” above.

Allowance for Credit Losses

The rollforward of the allowance for credit losses for private loans is shown below:

FOR THE PERIODS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Balance, as of January 1 $ (97) $ (44)
Provision (8) 2
Writeoffs charged against the allowance 1
Balance, as of March 31 $ (105) $ (41)

The Company’s private loans may be subject to loan modifications. Loan modifications may be granted to borrowers experiencing financial difficulties and could include term extensions. For the three months ended March 31, 2025 and 2024, the Company did not have a significant amount of private loans that it modified to borrowers experiencing financial difficulty.

Page 16

NOTE 7. INVESTMENT REAL ESTATE AND REAL ESTATE PARTNERSHIPS

The carrying amounts of investment real estate, net of accumulated depreciation, and real estate partnerships by property-type are as follows:

AS OF MAR. 31, 2025US MILLIONS, EXCEPT FOR PERCENTAGES Investment real estate(1) Real estate partnerships
Percentage Amount Percentage
Hotel $ 136 6 % $ 99 3 %
Industrial 5 1 % 79 2 %
Land 371 16 % 35 1 %
Office 296 12 % 1,909 55 %
Retail 182 8 % 738 21 %
Apartments 47 2 % 443 13 %
Single family residential 1,334 54 % %
Other 17 1 % 155 5 %
Total $ 2,388 100 % $ 3,458 100 %

All values are in US Dollars.

AS OF DEC. 31, 2024US MILLIONS, EXCEPT FOR PERCENTAGES Investment real estate(1) Real estate partnerships
Percentage Amount Percentage
Hotel $ 135 6 % $ 108 3 %
Industrial 14 1 % 83 2 %
Land 288 11 % 35 1 %
Office 338 14 % 2,090 61 %
Retail 186 8 % 705 21 %
Apartments 47 2 % 267 8 %
Single family residential 1,343 57 % %
Other 15 1 % 150 4 %
Total $ 2,366 100 % $ 3,438 100 %

All values are in US Dollars.

__________________________

(1)Investment real estate for single family residential property is fair valued as a result of consolidation of investment company VIE in accordance with ASC 946.

As of March 31, 2025, $14 million of real estate investments met the criteria as held-for-sale (December 31, 2024 – $12 million).

Page 17

NOTE 8. VARIABLE INTEREST ENTITIES AND EQUITY METHOD INVESTMENTS

Through its investment activities, the Company regularly invests in various entities including limited partnerships (“LPs”) and limited liability companies (“LLCs”) and frequently participates in the design with their sponsors, but in most cases, its involvement is limited to financing. Some of these entities have been determined to be VIEs. In certain instances, in addition to an economic interest in the entity, the Company holds the power to direct the most significant activities of the entity and is deemed the primary beneficiary. The Company consolidates all VIEs for which it is the primary beneficiary. The assets of consolidated VIEs are restricted and must first be used to settle their liabilities. Creditors or beneficial interest holders of these VIEs have no recourse to the general credit of the Company, as its obligation is limited to the amount of its committed investment. The Company has not provided financial or other support to these consolidated VIEs in the form of liquidity arrangements, guarantees or other commitments to third parties that may affect the fair value or risk of its variable interest in these VIEs as of March 31, 2025 and December 31, 2024.

In addition to investment activities, certain of the Company’s subsidiaries are deemed VIEs. The Company is the primary beneficiary and consolidates these entities in the same manner as other entities in which the Company has a controlling financial interest by holding a majority voting interest.

(a)Consolidated Variable Interest Entities

The assets and liabilities relating to the consolidated VIEs from the Company’s investment activities included in the financial statements are as follows:

AS OF<br>US$ MILLIONS March 31, 2025 December 31, 2024
Available-for-sale fixed maturity securities $ 103 $ 127
Equity securities 471 576
Mortgage loans on real estate, net of allowance 213 189
Private loans, net of allowance 1,559 1,384
Investment real estate 2,071 1,798
Real estate partnerships 2,939 2,885
Investment funds 5,260 4,804
Short-term investments 54
Other invested assets 370 144
Cash and cash equivalents 218 218
Other assets 176 404
Total assets of consolidated VIEs $ 13,434 $ 12,529
Notes payable 196 189
Other liabilities 322 363
Total liabilities of consolidated VIEs $ 518 $ 552

Page 18

(b)Unconsolidated Variable Interest Entities

For certain of the Company’s investments in various entities that are determined to be VIEs, the Company is not the primary beneficiary as it does not take an active role in the management of these investments. Such investments are reported in certain investment line items on the statements of financial position, including “Available-for-sale fixed maturity securities, at fair value” and “Investment funds”. In some instances, a consolidated VIE involves one or more underlying entities for which the Company is not the primary beneficiary because it does not have the power to direct the most significant activities of these entities. These unconsolidated VIEs that are part of consolidated VIEs are reported primarily in “Real estate partnerships” on the statements of financial position. Creditors or beneficial interest holders of the unconsolidated VIEs have no recourse to the general credit of the Company, as its obligation is limited to the amount of its committed investment. The Company has not provided financial or other support to these unconsolidated VIEs in the form of liquidity arrangements, guarantees or other commitments to third-parties that may affect the fair value or risk of its variable interest in these VIEs as of March 31, 2025 and December 31, 2024.

The carrying amount and maximum exposure to loss relating to these unconsolidated VIEs are as follows:

AS OFUS MILLIONS March 31, 2025 December 31, 2024
Maximum Exposure to Loss Carrying Amount Maximum Exposure to Loss
Available-for-sale fixed maturity securities $ 2,224 $ 3,086 $ 2,142 $ 3,003
Equity securities 464 464 466 466
Mortgage loans on real estate, net of allowance 675 680 716 731
Private loans, net of allowance 40 48
Real estate partnerships 2,852 2,856 2,548 2,579
Investment funds 3,623 4,083 1,989 2,153
Short-term investments 99 99
Other invested assets 155 183 173 189
Total $ 10,033 $ 11,400 $ 8,133 $ 9,220

All values are in US Dollars.

(c)Equity Method Investments

Our investments in investment funds, real estate partnerships and other partnerships, of which substantially all are LPs or LLCs, are accounted for using the equity method of accounting, except for certain investments that are fair valued due to the application of fair value option under ASC 825 or the consolidation of investment company VIE under ASC 946. As of March 31, 2025 and December 31, 2024, the Company’s equity method investments were $7.6 billion and $7.5 billion, respectively. Balance as of March 31, 2025 includes $949 million of equity method investments in common stock for which a quoted market price is available (December 31, 2024 – $901 million). The aggregate value of such investments based on the quoted market price as of March 31, 2025 was $1.0 billion (December 31, 2024 – $1.0 billion).

We generally recognize our share of earnings in our equity method investments within “Net investment income” using a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from our reporting period.

Page 19

NOTE 9. DERIVATIVE INSTRUMENTS

The Company manages risks associated with certain assets and liabilities by using derivative instruments. Derivative instruments are financial contracts whose value is derived from underlying interest rates, exchange rates or other financial instruments. The Company does not invest in derivatives for speculative purposes.

Foreign exchange forwards, options and swaps are over-the-counter contractual agreements negotiated between counterparties. The Company purchases equity-indexed options as economic hedges against fluctuations in the equity markets to which equity-indexed products are exposed. Equity-indexed contracts include a fixed host universal-life insurance or annuity contract and an equity-indexed embedded derivative. Futures contracts are traded in an organized market and are contractual obligations to buy or sell a financial instrument at a predetermined future time at a given price.

The notional principal represents the amount to which a rate or price is applied to determine the cash flows to be exchanged periodically and does not represent credit exposure. Maximum credit risk is the estimated cost of replacing derivative instruments which have a positive value, should the counterparty default.

Derivatives, except for embedded derivatives, are included in “Other invested assets” or “Other liabilities”, at fair value in the statements of financial position. Embedded derivatives on Modco arrangements, embedded derivatives on indexed annuity and variable annuity products and embedded derivatives on funds withheld arrangements are included in the statements of financial position within the “Reinsurance funds withheld”, “Policyholders’ account balances” and “Funds withheld for reinsurance liabilities” lines respectively, at fair value.

Page 20

The notional amounts and fair values of freestanding derivative instruments are shown below:

AS OF<br>US$ MILLIONS Primary underlying risk March 31, 2025 December 31, 2024
Notional Amount Fair Value(1) Notional Amount Fair Value(1)
Assets Liabilities Assets Liabilities
Derivatives designated as hedging instruments:
Foreign exchange forwards Foreign currency $ 1,352 $ 1 $ (34) $ 1,625 $ 21 $ (18)
Cross currency swaps Foreign currency 1,688 9 (31) 1,330 9 (16)
Interest rate swaps Interest rate 500 10
Derivatives not designated as hedging instruments:
Equity-indexed options Equity $ 46,436 $ 839 $ (3) $ 46,374 $ 1,311 $ (5)
Equity total return swaps Equity 57 (4) 18 1
Foreign exchange forwards Foreign currency 2,578 7 (31) 3,684 34 (9)
Cross currency swaps Foreign currency 37 1 38
Interest rate swaps Interest rate 985 17 (6) 985 15 (9)
$ 53,633 $ 884 $ (109) $ 54,054 $ 1,391 $ (57)

__________________________

(1)The asset and liability balances are presented on a gross basis. Amounts are reported in “Other invested assets” and “Other liabilities” in the statements of financial position after the evaluation for rights of offset. See “Derivative Exposure” section of this note for further details.

Page 21

Derivatives Designated as Hedging Instruments

The Company has designated and accounted for certain foreign exchange forwards and cross currency swaps (together “foreign currency derivatives”) as fair value hedges to protect a portion of the available-for-sale fixed maturity securities against changes in fair value due to changes in exchange rates. The Company has also designated and accounted for certain interest rate swaps (“interest rate derivatives”) as fair value hedges to convert a portion of PAB from a fixed rate liability to a floating rate liability.

For derivative instruments that were designated and qualified as fair value hedges, the gain or loss on the portion of the derivative instrument included in the assessment of hedge effectiveness and the offsetting gain or loss on the hedged item attributable to the hedged risk are recognized in the same line item in the statements of operations. The unrealized gain or loss attributable to changes in exchange rates on the available-for-sale fixed maturity securities that were designated as part of the hedge are reclassified out of other comprehensive income (“OCI”) into “Investment related gains (losses)” in the statements of operations. The remaining change in unrealized gain or loss on the hedged item not associated with the risk being hedged remains as a component of OCI. The gains (losses) on interest rate derivatives designated as hedging instruments for certain PAB are included in “Interest sensitive contract benefits” in the statements of operations.

The following represents the amount of gains (losses) related to the derivatives and hedged items that qualify for fair value hedges:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Foreign currency derivatives:
Hedged items $ 35 $ 41
Derivatives designated as hedging instruments (35) (41)
Interest rate derivatives:
Hedged items 10
Derivatives designated as hedging instruments (10)
Gains (losses) on fair value hedges $ $

The following table presents the carrying amount and cumulative fair value hedging adjustments for a portion of PAB designated and qualifying as hedged items in fair value hedges:

AS OF<br><br>US$ MILLIONS Carrying Amount of the Hedged Assets (Liabilities) Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedge Assets (Liabilities)
Location in the statements of financial position March 31, 2025 December 31, 2024 March 31, 2025 December 31, 2024
Policyholders’ account balances $ (505) $ $ (10) $

Page 22

Derivatives Not Designated as Hedging Instruments

The following represents the amount of gains (losses) related to the derivatives not designated as hedging instruments, recognized in “Investment related gains (losses)” on the statements of operations, except for equity-indexed options which are recognized in “Change in fair value of insurance-related derivatives and embedded derivatives”:

FOR THE THREE MONTHS ENDED MAR. 31US MILLIONS 2025 2024
Equity-indexed options (334) $ 100
Equity total return swaps 13
Foreign exchange forwards 4
Cross currency swaps
Interest rate swaps (3)
Bond futures (4)
Total $ (364) $ 97

All values are in US Dollars.

Derivative Exposure

The Company’s use of derivative instruments exposes it to credit risk in the event of non-performance by counterparties. The Company has a policy of only dealing with counterparties it believes are creditworthy and obtaining sufficient collateral where appropriate, as a means to mitigating the financial loss from defaults. The minimum credit rating of our counterparties is BBB+ as of March 31, 2025 (December 31, 2024 – BBB+), and all derivatives have been appropriately collateralized by the Company and the counterparties in accordance with the terms of the derivative agreements. The Company holds collateral in cash and notes secured by U.S. government-backed assets. The non-performance risk is the net counterparty exposure based on fair value of open contracts less fair value of collateral held. The Company maintains master netting agreements with its current active trading partners. A right of offset has been applied to cash collateral that supports credit risk and has been recorded in the statements of financial position as an offset to “Other invested assets” with an associated payable to “Other liabilities” for non-cash and excess collateral. A right of offset has also been applied to derivative assets and liabilities with the same counterparty under the same master netting agreement, and such derivative instruments are presented on a net basis in the statements of financial position.

Page 23

Information regarding the Company’s exposure to credit loss on the derivatives it holds, including the effect of rights of offset, is presented below:

AS OF MAR. 31, 2025<br>US$ MILLIONS Gross amount of derivative instruments(1) Gross amounts offset in the statements of financial position(2) Net amount presented on the statements of financial position Collateral (received) pledged in cash(3) Collateral (received) pledged in invested assets(3) Exposure net of collateral
Derivative assets:
Equity-indexed options $ 839 $ (16) $ 823 $ (762) $ (21) $ 40
Foreign exchange forwards 8 (8)
Cross currency swaps 10 (10)
Interest rate swaps 27 (17) 10 10
Total derivative assets $ 884 $ (51) $ 833 $ (762) $ (21) $ 50
Derivative liabilities:
Equity-indexed options $ (3) $ 3 $ $ $ $
Equity total return swaps (4) (4) (4)
Foreign exchange forwards (65) 32 (33) 4 (29)
Cross currency swaps (31) 10 (21) 1 (20)
Interest rate swaps (6) 6
Total derivative liabilities $ (109) $ 51 $ (58) $ $ 5 $ (53)

__________________________

(1)Represents derivative assets and liabilities on a gross basis, which are not offset under enforceable master netting agreements that meet all offsetting criteria.

(2)Represents netting of derivative exposures covered by qualifying master netting agreements.

(3)Excludes a portion of collaterals held in cash and invested assets that are excess collateral. As of March 31, 2025, the Company held excess collateral of $16 million.

Page 24

AS OF DEC. 31, 2024<br>US$ MILLIONS Gross amount of derivative instruments(1) Gross amounts offset in the statements of financial position(2) Net amount presented on the statements of financial position Collateral (received) pledged in cash(3) Collateral (received) pledged in invested assets(3) Exposure net of collateral
Derivative assets:
Equity-indexed options $ 1,311 $ (5) $ 1,306 $ (1,298) $ $ 8
Equity total return swaps 1 1 1
Foreign exchange forwards 55 (1) 54 54
Cross currency swaps 9 (9)
Interest rate swaps 15 (15)
Total derivative assets $ 1,391 $ (30) $ 1,361 $ (1,298) $ $ 63
Derivative liabilities:
Equity-indexed options (5) 5 $ $
Foreign exchange forwards $ (27) $ 7 $ (20) $ $ 18 $ (2)
Cross currency swaps (16) 9 (7) 5 (2)
Interest rate swaps (9) 9
Total derivative liabilities $ (57) $ 30 $ (27) $ $ 23 $ (4)

__________________________

(1)Represents derivative assets and liabilities on a gross basis, which are not offset under enforceable master netting agreements that meet all offsetting criteria.

(2)Represents netting of derivative exposures covered by qualifying master netting agreements.

(3)Excludes a portion of collaterals held in cash and invested assets that are excess collateral. As of December 31, 2024, the Company held excess collateral of $76 million.

Page 25

Embedded Derivatives

The fair values of embedded derivatives that have been separated from their host contracts, presented in the statements of financial position, are shown below:

AS OF <br>US$ MILLIONS Location in the statements of financial position March 31, 2025 December 31, 2024
Fair Value Fair Value
Assets Liabilities Assets Liabilities
Modco arrangement Reinsurance funds withheld $ 8 $ $ 18 $
Indexed annuity and variable annuity product Policyholders’ account balances (948) (1,123)
Funds withheld arrangement Funds withheld for reinsurance liabilities (55) (37)
$ 8 $ (1,003) $ 18 $ (1,160)

The following represents the amount of gains (losses) related to embedded derivatives recorded in the statements of operations:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS Location in the statements of operations 2025 2024
Modco arrangement Net investment results from reinsurance funds withheld $ (10) $ 135
Indexed annuity and variable annuity product Change in fair value of insurance-related derivatives and embedded derivatives 155 (57)
Funds withheld arrangement Change in fair value of insurance-related derivatives and embedded derivatives (21) 1
$ 124 $ 79

Page 26

NOTE 10. NET INVESTMENT INCOME AND INVESTMENT RELATED GAINS (LOSSES)

Net investment income is shown below:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Available-for-sale fixed maturity securities $ 748 $ 313
Equity securities 18 11
Mortgage loans 218 83
Private loans 116 31
Investment real estate 1 5
Real estate partnerships 39 (6)
Investment funds 129 43
Policy loans 6 6
Short-term investments 96 51
Other invested assets 42 37
Total net investment income $ 1,413 $ 574

Net unrealized and realized investment gains (losses) are shown below:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Available-for-sale fixed maturity securities $ 21 $ 12
Equity securities (182) 20
Mortgage loans 8 (8)
Private loans 11 4
Investment real estate (8) (17)
Real estate partnerships 5
Short-term investments and other invested assets 42 33
Total investment related gains (losses) $ (103) $ 44

Page 27

NOTE 11. FAIR VALUE OF FINANCIAL INSTRUMENTS

The carrying amount and fair value of financial instruments are shown below:

March 31, 2025 December 31, 2024
AS OF<br>US$ MILLIONS Carrying Amount Fair Value Carrying Amount Fair Value
Financial assets
Available-for-sale fixed maturity securities $ 55,759 $ 55,759 $ 53,802 $ 53,802
Equity securities 3,468 3,468 3,854 3,854
Mortgage loans on real estate, net of allowance 11,901 11,767 12,426 12,240
Private loans, net of allowance 5,600 5,593 5,204 5,320
Real estate partnerships(1) 1,525 1,525 1,487 1,487
Policy loans 265 265 276 276
Short-term investments(2) 8,425 8,425 4,400 4,400
Other invested assets:
Derivative assets 833 833 1,361 1,361
Separately managed accounts 71 71 71 71
Other(3)(4) 988 993 956 958
Cash and cash equivalents 8,261 8,261 12,243 12,243
Reinsurance funds withheld – embedded derivative 8 8 18 18
Other assets – market risk benefit assets 945 945 856 856
Separate account assets(5) 1,253 1,253 1,343 1,343
Total financial assets $ 99,302 $ 99,166 $ 98,297 $ 98,229
Financial liabilities
Policyholders’ account balances – embedded derivative $ 948 $ 948 $ 1,123 $ 1,123
Market risk benefits 4,066 4,066 3,655 3,655
Notes payable 196 196 189 189
Corporate and subsidiary borrowings 4,336 4,365 4,351 4,371
Funds withheld for reinsurance liabilities – embedded derivative 55 55 37 37
Other liabilities – derivative liabilities 58 58 27 27
Separate account liabilities(5) 1,253 1,253 1,343 1,343
Total financial liabilities $ 10,912 $ 10,941 $ 10,725 $ 10,745

__________________________

(1)Balance represents financial assets that are fair valued in accordance with ASC 825.

(2)Balance includes $400 million and $400 million of amounts loaned under reverse repurchase agreements as of March 31, 2025 and December 31, 2024, respectively. The fair values of the collateral received under these agreements were $859 million and $783 million as of March 31, 2025 and December 31, 2024, respectively.

(3)Balances include $640 million and $637 million of other invested assets not subject to the fair value hierarchy as of March 31, 2025 and December 31, 2024, respectively.

(4)Balances exclude $783 million and $1.3 billion of derivative collaterals that are recorded as an offset to “Other invested assets” in the statements of financial position and are also not included in the fair value hierarchy as of March 31, 2025 and December 31, 2024, respectively (refer to “Derivative Exposure” section of Note 9 for details).

(5)Balances include $30 million and $31 million of assets, and corresponding liabilities, that are not subject to the fair value hierarchy as of March 31, 2025 and December 31, 2024, respectively.

Page 28

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability. A fair value hierarchy is used to determine fair value based on a hypothetical transaction as of the measurement date from the perspective of a market participant. The Company has evaluated the types of securities in its investment portfolio to determine an appropriate hierarchy level based upon trading activity and the observability of market inputs. The classification of assets or liabilities within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels are defined as follows:

Level 1 Unadjusted quoted prices in active markets for identical assets or liabilities
Level 2 Quoted prices in markets that are not active or inputs that are observable directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities other than quoted prices in Level 1; quoted prices in markets that are not active; or other inputs that are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities
Level 3 Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Unobservable inputs reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Level 3 assets and liabilities include financial instruments whose values are determined using pricing models and third-party evaluation, as well as instruments for which the determination of fair value requires significant management judgment or estimation

Valuation Techniques for Assets and Liabilities Recorded at Fair Value

Available-for-sale fixed maturity securities — The Company utilizes pricing services to estimate fair value measurements. The fair value for available-for-sale fixed maturity securities that are disclosed as Level 1 measurements are based on unadjusted quoted market prices for identical assets that are readily available in an active market. The estimates of fair value for most available-for-sale fixed maturity securities, including municipal bonds, provided by the pricing service are disclosed as Level 2 measurements as the estimates are based on observable market information rather than market quotes. The pricing service utilizes market quotations for available-for-sale fixed maturity securities that have quoted prices in active markets. Since available-for-sale fixed maturity securities generally do not trade on a daily basis, the pricing service prepares estimates of fair value measurements for these securities using its proprietary pricing applications, which include available relevant market information, benchmark curves, benchmarking of like securities, sector groupings and matrix pricing. Additionally, an option adjusted spread model is used to develop prepayment and interest rate scenarios.

The pricing service evaluates each asset class based on relevant market information, credit information, perceived market movements and sector news. The market inputs utilized in the pricing evaluation, listed in the approximate order of priority, include: benchmark yields, reported trades, pricing source quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and economic events. The extent of the use of each market input depends on asset class and the market conditions. Depending on the security, the priority of the use of inputs may change or some market inputs may not be relevant. For some securities, additional inputs may be necessary.

The Company has reviewed the inputs and methodology used and the techniques applied by the pricing service to produce quotes that represent the fair value of a specific security. The review confirms that the pricing service is utilizing information from observable transactions or a technique that represents a market participant’s assumptions. The Company does not adjust quotes received from the pricing service. The pricing service utilized by the Company has indicated that they will only produce an estimate of fair value if there is objectively verifiable information available.

The Company holds a small amount of private placement debt and available-for-sale fixed maturity securities that have characteristics that make them unsuitable for matrix pricing. For these securities, a quote from an independent pricing source (typically a market maker) is obtained. Due to the disclaimers on the quotes that indicate the price is indicative only, the Company includes these fair value estimates in Level 3.

For securities priced using a quote from an independent pricing source, such as certain available-for-sale fixed maturity securities, the Company uses a market-based fair value analysis to validate the reasonableness of prices received. Price variances above a certain threshold are analyzed further to determine if any pricing issue exists. This analysis is performed quarterly.

Page 29

Equity securities — For publicly-traded equity securities, prices are received from a nationally recognized pricing service that are based on observable market transactions, and these securities are classified as Level 1 measurements. For certain preferred stock, current market quotes in active markets are unavailable. In these instances, an estimated fair value is received from the pricing service. The service utilizes similar methodologies to price preferred stocks as it does for available-for-sale fixed maturity securities. If applicable, these estimates are disclosed as Level 2 or Level 3 measurements, depending on the use of at least one significant unobservable input. The Company tests the accuracy of the information provided by reference to other services annually.

Short-term investments — Short-term investments include fixed maturity securities with original maturities of over 90 days and less than one year at the date of acquisition, some of which are disclosed as Level 1 measurements as their fair values are based on unadjusted quoted market prices for identical assets that are readily available in an active market. Short-term investments also include commercial paper rated A2 or P2 or better by Standard & Poor’s and Moody’s, respectively, as well as certain private loans with original maturities of less than one year at the date of acquisition and amounts loaned under reverse repurchase agreements. Commercial paper, short-term private loans and amounts loaned under reverse repurchase agreements are carried at amortized cost which approximates fair value. These investments are classified as Level 2 or Level 3 measurements, depending on the use of at least one significant unobservable input.

Investment real estate and real estate partnerships — The fair values of residential real estate investments held through consolidation of investment company VIEs are initially recorded based on the cost to purchase the properties and subsequently recorded at fair value on a recurring basis and falls within Level 3 of the fair value hierarchy. The fair value of the residential real estate properties was determined using broker price opinions (“BPO”). A BPO is an appraisal methodology commonly used in the industry to estimate net proceeds from the sale of a home. The significant inputs into the valuation include market comparable home sales, age and size of the home, location and property conditions.

For certain of the Company’s interest in unconsolidated variable interest entities, the Company elected the fair value option in accordance with ASC 825. The fair value of such interest is derived using discounted cash flow methodology and falls within Level 3 of the fair value hierarchy.

Certain of the Company’s consolidated variable interest entities that are fair valued on a recurring basis invest in LLCs that invest in operating entities which hold multi-family real estate properties. The fair value of the LLCs is obtained from a third party and is based on the fair value of the underlying real estate held by the various operating entities. The real estate is initially calculated based on the cost to purchase the properties and subsequently calculated based on a discounted cash flow methodology. Such investments are classified as Level 3 measurements.

Investment funds — The Company owns certain investments in infrastructure LLCs through a consolidated VIE that is measured at fair value on a recurring basis. We initially recorded the investment at the cost to purchase the investment and subsequently recorded based on a discounted cash flow methodology. Investment funds that are fair valued are classified as Level 3 measurements. Certain LP funds are measured at estimated fair value using net asset value (“NAV”) as a practical expedient.

Other invested assets — The Company holds interest in an investment company limited partnership, which invests in residual tranche investments, and is a consolidated VIE. We also hold residual tranche investments to which we applied the fair value option in accordance with ASC 825. These investments were initially recorded at cost and are subsequently recorded at fair value using discounted cash flow methodology and falls within Level 3 of the fair value hierarchy.

Separate account assets and liabilities — The separate account assets included on the quantitative disclosures fair value hierarchy table are comprised of short-term investments, equity securities, and available-for-sale fixed maturity. Equity securities are classified as Level 1 measurements. Short-term investments and available-for-sale fixed maturity securities are classified as Level 2 measurements. These classifications for separate account assets reflect the same fair value level methodologies as listed above as they are derived from the same vendors and follow the same process. The separate account assets also include cash and cash equivalents, investment funds, accrued investment income, and receivables for securities. These are not included in the quantitative disclosures of fair value hierarchy table.

Reinsurance funds withheld – embedded derivatives — Valuation model is based on quoted prices of similar, traded securities in active markets. For example, interest rates and yield curves observed at commonly quoted intervals, implied volatility, credit spread and market-corroborated inputs.

Page 30

Market risk benefits — MRBs are valued using stochastic models that incorporate a spread reflecting our non-performance risk. The key assumptions for calculating the fair value of the MRBs are market assumptions such as equity market returns, interest rate levels, market volatility and correlations and policyholder behavior assumptions such as lapse, mortality, utilization and withdrawal patterns. Risk margins are included in the policyholder behavior assumptions. The assumptions are based on a combination of historical data and actuarial judgment. MRBs are classified as Level 3 fair value measurements as the fair value is based on unobservable inputs. The following significant unobservable inputs are used for measuring the fair value:

•Utilization – The utilization assumption represents the percentage of policyholders who will elect to receive lifetime income benefit payments in a given year. The range and weighted average of this assumption can vary from year to year depending on the characteristics of policies in a given cohort within the rate.

•Option budget – The option budget assumption represents the expected cost of annual call options we will purchase in the future.

•Non-performance risk – The non-performance risk assumption impacts the discount rate used in the discounted future cash flow valuation and includes the Company’s own credit risk based on the current market credit spreads for debt-like instruments the Company has issued and are available in the market. Additionally, the non-performance risk assumption includes the counterparty credit risk used in the fair value measurement of ceded market risk benefits which is determined using the current market credit spreads based on the counterparty credit rating.

•Mortality rates – The mortality rate assumptions are set based on a combination of company and industry experience, adjusted for improvement factors. Mortality rates vary by age and by demographic characteristics such as gender.

•Lapse rates – The lapse rate assumptions represent the expected rate of full surrenders which are set based on product type or feature and whether a policy is subject to surrender charges.

Derivative assets and liabilities:

•Foreign currency forward contracts – discounted cash flow model – forward exchange rates (from observable forward exchange rates at the end of the reporting period); discounted at a credit adjusted rate.

•Interest rate contracts – discounted cash flow model – forward interest rates (from observable yield curves) and applicable credit spreads discounted at a credit adjusted rate.

•Equity-index options – valued using industry accepted valuation models and are adjusted for the non-performance risk of each counterparty net of any collateral held. Inputs include market volatility and risk free interest rates and are used in income valuation techniques in arriving at a fair value for each option contract. The non-performance risk for each counterparty is based upon its credit default swap rate. The Company has no performance obligations related to the equity-index options purchased to fund its fixed index annuity and equity-indexed universal life policy liabilities. Certain equity-index options are valued based on vendor sourced prices and are classified as Level 3 measurements due to the use of significant unobservable inputs used by the vendor.

Policyholders’ account balances – embedded derivatives — The fair value of the embedded derivative component of the Company’fixed index annuity and equity-indexed universal life policyholder’s account balances is estimated at each valuation date by (i) projecting policy contract values and minimum guaranteed contract values over the expected lives of the contracts and (ii) discounting the excess of the projected contract value amounts at the applicable risk free interest rates adjusted for the Company’s non-performance risk related to those liabilities. The following significant unobservable inputs are used for measuring the fair value: (i) Option budget; (ii) Lapse rates; and (iii) Non-performance risk. For the details of these significant unobservable inputs, refer to significant unobservable inputs for “Market risk benefits”.

Funds withheld for reinsurance liabilities – embedded derivatives — The fair value of the embedded derivative is estimated based on the fair value of the assets supporting the funds withheld payable under modified coinsurance and funds withheld coinsurance reinsurance agreements. The fair value of the embedded derivative is classified as Level 3 based on valuation methods used for the assets held supporting the reinsurance agreements.

Separately managed accounts — The separately managed account manager uses the mid-point of a range from a third-party to price these securities. Discounted cash flows (yield analysis) and market transactions approach are used in the valuation. They use discount rates which is considered an unobservable input.

Page 31

The fair value hierarchy measurements of the assets and liabilities recorded at fair value are shown below:

AS OF MAR. 31, 2025<br>US$ MILLIONS Total Fair Value Level 1 Level 2 Level 3
Financial assets
Available-for-sale fixed maturity securities:
U.S. treasury and government $ 364 $ 304 $ 60 $
U.S. state and municipal 3,282 3,226 56
Foreign governments 1,651 1,651
Corporate debt securities 37,977 36,556 1,421
Residential mortgage-backed securities 1,228 1,194 34
Commercial mortgage-backed securities 3,469 3,396 73
Collateralized debt securities 7,788 3,184 4,604
Total fixed maturity, available-for-sale 55,759 304 49,267 6,188
Equity securities:
Common stock 3,043 2,606 2 435
Preferred stock 421 35 6 380
Private equity and other 4 4
Total equity securities 3,468 2,641 8 819
Investment real estate(1) 1,275 1,275
Real estate partnerships(1)(2) 1,567 1,567
Investment funds(1)(3) 130 130
Short-term investments 8,425 7,447 566 412
Other invested assets:
Derivative assets 833 684 149
Separately managed accounts 71 71
Other(2) 348 1 347
Cash and cash equivalents 8,261 8,261
Reinsurance funds withheld – embedded derivative 8 8
Premiums due and other receivables – derivative asset 22 22
Other assets – market risk benefit assets 945 945
Separate account assets 1,223 896 327
Total financial assets $ 82,335 $ 19,549 $ 50,875 $ 11,911
Financial liabilities
Policyholders’ account balances – embedded derivative $ 948 $ $ $ 948
Market risk benefits 4,066 4,066
Funds withheld for reinsurance liabilities – embedded derivative 55 55
Other liabilities – derivative liabilities 58 58
Separate account liabilities 1,223 896 327
Total financial liabilities $ 6,350 $ 896 $ 385 $ 5,069

__________________________

(1)Balances include financial assets that are fair valued as a result of consolidation of investment company VIE in accordance with ASC 946.

(2)$1.5 billion of real estate partnerships and $172 million of other invested assets are financial assets that are fair valued in accordance with ASC 825.

(3)Balance for investment funds excludes those measured at estimated fair value using NAV per share as a practical expedient. As of March 31, 2025, the estimated fair values of investment funds measured at NAV as a practical expedient were $373 million.

Page 32

AS OF DEC. 31, 2024<br>US$ MILLIONS Total Fair Value Level 1 Level 2 Level 3
Financial assets
Available-for-sale fixed maturity securities:
U.S. treasury and government $ 369 $ 310 $ 59 $
U.S. state and municipal 3,289 3,233 56
Foreign governments 2,042 2,042
Corporate debt securities 37,380 34,696 2,684
Residential mortgage-backed securities 1,310 1,291 19
Commercial mortgage-backed securities 3,320 3,245 75
Collateralized debt securities 6,092 3,447 2,645
Total fixed maturity, available-for-sale 53,802 310 48,013 5,479
Equity securities:
Common stock 3,412 2,858 2 552
Preferred stock 438 36 12 390
Private equity and other 4 4
Total equity securities 3,854 2,894 14 946
Investment real estate(1) 1,283 1,283
Real estate partnerships(1)(2) 1,529 1,529
Investment funds(1)(3) 124 124
Short-term investments 4,400 3,213 834 353
Other invested assets:
Derivative assets 1,361 1,138 223
Separately managed accounts 71 71
Other(2) 319 11 308
Cash and cash equivalents 12,243 12,243
Reinsurance funds withheld – embedded derivative 18 18
Premiums due and other receivables – derivative asset 22 22
Other assets - market risk benefit assets 856 856
Separate account assets 1,312 258 1,054
Total financial assets $ 81,194 $ 18,918 $ 51,086 $ 11,190
Financial liabilities
Policyholders’ account balances – embedded derivative $ 1,123 $ $ $ 1,123
Market risk benefits 3,655 3,655
Funds withheld for reinsurance liabilities - embedded derivative 37 37
Other liabilities – derivative liabilities 27 27
Separate account liabilities 1,312 258 1,054
Total financial liabilities $ 6,154 $ 258 $ 1,081 $ 4,815

__________________________

(1)Balances include financial assets that are fair valued as a result of consolidation of investment company VIE in accordance with ASC 946.

(2)$1.5 billion of real estate partnerships and $171 million of other invested assets are financial assets that are fair valued in accordance with ASC 825.

(3)Balance for investment funds excludes those measured at estimated fair value using NAV per share as a practical expedient. As of December 31, 2024, the estimated fair values of investment funds measured at NAV as a practical expedient were $380 million.

Page 33

Fair Value Information About Financial Instruments Not Recorded at Fair Value

Information about fair value estimates for financial instruments not recorded at fair value is discussed below:

Mortgage loans — The fair value of mortgage loans is estimated using discounted cash flow analyses on a loan-by-loan basis by applying a discount rate to expected cash flows from future installment and balloon payments. The discount rate takes into account general market trends and specific credit risk trends for the individual loan. Factors used to arrive at the discount rate include inputs from spreads based on U.S. Treasury notes and the loan’s credit quality, region, property-type, lien priority, payment type and current status.

Private loans — The fair value of private loans is estimated using discounted cash flow analyses on a loan-by-loan basis by applying a discount rate to expected cash flows from future installment and balloon payments. The discount rate takes into account general market trends and specific credit risk trends for the individual loan.

Policy loans — The carrying value of policy loans is the outstanding balance plus any accrued interest. Due to the collateralized nature of policy loans such that they cannot be separated from the policy contracts, the unpredictable timing of repayments and the fact that settlement is at outstanding value, the carrying value of policy loans approximates fair value.

Other invested assets — The common stock of Federal Home Loan Banks (“FHLB”) is carried at cost which approximates fair value. The fair value of the company owned life insurance (“COLI”) is equal to the cash surrender value of the policies.

Corporate and subsidiary borrowings — Corporate and subsidiary borrowings are carried at outstanding principal balance. Fair values for subordinated debentures are estimated using discounted cash flow calculations principally based on observable inputs including the Company’s incremental borrowing rates, which reflect its credit rating, for similar types of borrowings with maturities consistent with those remaining for the debt being valued.

Notes payable — Notes payable are carried at outstanding principal balance. For a majority of the notes, the carrying value of the notes payable approximates fair value because the underlying interest rates approximate market rates at the reporting date.

Policyholder’s account balances & deposit assets excluding embedded derivative — The fair values of the policyholder’s account balances not involving significant mortality or morbidity risks are stated at the cost we would incur to extinguish the liability (i.e., the cash surrender value) as these contracts are generally issued without an annuitization date. The coinsurance deposits related to the annuity benefit reserves have fair values determined in a similar fashion. For period-certain annuity benefit contracts, the fair value is determined by discounting the benefits at the interest rates currently in effect for newly issued immediate annuity contracts. All of the fair values presented within these categories fall within Level 3 of the fair value hierarchy as most of the inputs are unobservable market data.

Page 34

The carrying amount and estimated fair value of financial instruments not recorded at fair value are shown below. The table below excludes accrued investment income, which is recorded at amortized cost in the statements of financial position, as their carrying amounts approximate the fair values due to their short-term nature.

AS OF MAR. 31, 2025US MILLIONS Carrying Amount Fair Value FV Hierarchy Level
Level 1 Level 2 Level 3
Financial assets
Mortgage loans on real estate, net of allowance $ 11,901 $ 11,767 11,767
Private loans, net of allowance 5,600 5,593 97 5,496
Policy loans 265 265 265
Deposit assets 5,976 5,868 5,868
Other invested assets, excluding derivatives and separately managed accounts 640 645 410 235
Total financial assets 24,382 $ 24,138
Financial liabilities
Policyholders’ account balances – investment contracts, excluding embedded derivative $ 81,060 $ 81,054 81,054
Corporate and subsidiary borrowings 4,336 4,365 4,365
Notes payable 196 196 196
Total financial liabilities 85,592 $ 85,615

All values are in US Dollars.

AS OF DEC. 31, 2024US MILLIONS Carrying Amount Fair Value FV Hierarchy Level
Level 1 Level 2 Level 3
Financial assets
Mortgage loans on real estate, net of allowance $ 12,426 $ 12,240 12,240
Private loans, net of allowance 5,204 5,320 153 5,167
Policy loans 276 276 276
Deposit assets 6,165 6,026 6,026
Other invested assets, excluding derivatives and separately managed accounts 637 639 408 231
Total financial assets 24,708 $ 24,501
Financial liabilities
Policyholders’ account balances – investment contracts, excluding embedded derivative $ 79,383 $ 79,383 79,383
Corporate and subsidiary borrowings 4,351 4,371 4,371
Notes payable 189 189 189
Total financial liabilities 83,923 $ 83,943

All values are in US Dollars.

Page 35

For financial assets and financial liabilities measured at fair value on a recurring basis using Level 3 inputs during the periods, reconciliations of the beginning and ending balances are shown below:

Assets Liabilities
FOR THE PERIOD ENDED MAR. 31, 2025<br>US$ MILLIONS Invested assets(1) Derivative assets Reinsurance funds withheld – embedded derivative Policyholders’ account balances – embedded derivative Funds withheld for reinsurance liabilities – embedded derivative
Balance as of January 1, 2025 $ 10,093 $ 223 $ 18 $ (1,123) $ (37)
Fair value changes in net income (32) (38) (10) 268 (18)
Fair value changes in other comprehensive income 20
Purchases 172 33
Sales (45)
Settlements or maturities (13) (69)
Premiums less benefits (93)
Transfers into Level 3 681
Transfers out of Level 3 (67)
Balance as of March 31, 2025 $ 10,809 $ 149 $ 8 $ (948) $ (55) Assets Liabilities
--- --- --- --- --- --- --- --- --- --- ---
FOR THE PERIOD ENDED MAR. 31, 2024<br>US$ MILLIONS Invested assets(1) Derivative assets Reinsurance funds withheld – embedded derivative Policyholders’ account balances – embedded derivative Funds withheld for reinsurance liabilities – embedded derivative
Balance as of January 1, 2024 $ 4,447 $ 227 $ (46) $ (872) $
Fair value changes in net income (5) 57 135 (38) 1
Fair value changes in other comprehensive income 8
Purchases 2,187 35
Sales (2,056)
Settlements or maturities (6) (62)
Premiums less benefits 6
Balance as of March 31, 2024 $ 4,575 $ 257 $ 89 $ (904) $ 1

__________________________

(1)Include separately managed accounts.

There were no transfers between Level 1 or Level 2 during the periods presented. Transfers into and out of Level 3 for the period ended March 31, 2025 were primarily the result of changes in observable pricing. The Company’s valuation of financial instruments categorized as Level 3 in the fair value hierarchy are based on valuation techniques that use significant inputs that are unobservable or had a decline in market activity that obscured observability. The indicators considered in determining whether a significant decrease in the volume and level of activity for a specific asset has occurred include the level of new issuances in the primary market, trading volume in the secondary market, the level of credit spreads over historical levels, applicable bid-ask spreads, and price consensus among market participants and other pricing sources. Level 3 assets and liabilities include financial instruments whose values are determined using pricing models and discounted cash flow methodology based on spread/yield assumptions.

Page 36

NOTE 12. REINSURANCE

The Company reinsures its business through a diversified group of reinsurers. The Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances is evaluated by monitoring ratings and the financial strength of its reinsurers. The effect of reinsurance on the applicable line items on our statements of operations are as follows:

FOR THE THREE MONTHS ENDED MAR. 31 <br>US$ MILLIONS 2025 2024
Premiums earned:
Gross amounts, including reinsurance assumed $ 1,490 $ 2,061
Reinsurance ceded (368) (530)
Net amount $ 1,122 $ 1,531
Other policy revenue:
Gross amounts, including reinsurance assumed $ 257 $ 112
Reinsurance ceded (78)
Net amount $ 179 $ 112
Policyholder benefits and claims incurred:
Gross amounts, including reinsurance assumed $ (1,409) $ (1,729)
Reinsurance ceded 302 315
Net amount $ (1,107) $ (1,414)
Interest sensitive contract benefits:
Gross amounts, including reinsurance assumed $ (562) $ (289)
Reinsurance ceded 38 104
Net amount $ (524) $ (185)
Change in fair value of market risk benefits:
Gross amounts, including reinsurance assumed $ (392) $ (31)
Reinsurance ceded 31
Net amount $ (361) $ (31)

Following the effective settlement of a reinsurance arrangement between NER SPC and AEL in the second quarter of 2024 (see Note 16 for details), our reinsurance assumed exposure is principally limited to the amounts of reinsurance funds withheld asset and associated deposit liability based on deposit accounting as presented in the statements of financial position, as well as certain future policy benefits liability.

Furthermore, certain of our subsidiaries have intercompany reinsurance agreements with its wholly owned reinsurance companies, some of which are captive reinsurance companies. All intercompany balances arising from such intercompany reinsurance agreements are eliminated in full on consolidation.

Page 37

NOTE 13. SEPARATE ACCOUNT ASSETS AND LIABILITIES

The following table presents the change of the Company’s separate account assets and liabilities:

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Balance, beginning of period $ 1,343 $ 1,189
Additions (deductions):
Policyholder deposits 19 20
Net investment income 23 9
Net realized capital gains on investments (43) 96
Policyholder benefits and withdrawals (31) (48)
Net transfer from (to) general account (54) 22
Policy charges (4) (3)
Total changes (90) 96
Balance, end of period $ 1,253 $ 1,285
Cash surrender value $ 686 $ 724

Page 38

NOTE 14. DEFERRED POLICY ACQUISITION COSTS, DEFERRED SALES INDUCEMENTS AND VALUE OF BUSINESS ACQUIRED

The following tables present a rollforward of DAC, deferred sales inducements (“DSI”) and value of business acquired (“VOBA asset”) for the periods indicated:

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31, 2025<br>US$ MILLIONS Annuities P&C Life Insurance Total
DAC:
Balance, beginning of period $ 886 $ 184 $ 306 $ 1,376
Additions 223 102 24 349
Amortization (20) (107) (6) (133)
Net change 203 (5) 18 216
Balance, end of period $ 1,089 $ 179 $ 324 $ 1,592
DSI:
Balance, beginning of period $ 393 $ $ $ 393
Additions 142 142
Amortization (8) (8)
Net change 134 134
Balance, end of period $ 527 $ $ $ 527
VOBA asset:
Balance, beginning of period $ 8,838 $ 27 $ 62 $ 8,927
Amortization (194) (3) (1) (198)
Net change (194) (3) (1) (198)
Balance, end of period $ 8,644 $ 24 $ 61 $ 8,729
Total DAC, DSI and VOBA asset $ 10,260 $ 203 $ 385 $ 10,848

Page 39

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31, 2024<br>US$ MILLIONS Annuities P&C Life Insurance Total
DAC:
Balance, beginning of period $ 1,314 $ 171 $ 217 $ 1,702
Additions 48 154 31 233
Amortization (23) (153) (5) (181)
Net change 25 1 26 52
Balance, end of period $ 1,339 $ 172 $ 243 $ 1,754
DSI:
Balance, beginning of period $ 257 $ $ $ 257
Additions 2 2
Amortization (3) (3)
Net change (1) (1)
Balance, end of period $ 256 $ $ $ 256
VOBA asset:
Balance, beginning of period $ 40 $ 168 $ 301 $ 509
Amortization (1) (35) (5) (41)
Net change (1) (35) (5) (41)
Balance, end of period $ 39 $ 133 $ 296 $ 468
Total DAC, DSI and VOBA asset $ 1,634 $ 305 $ 539 $ 2,478

The following table provides the projected VOBA asset amortization expenses for a five-year period and thereafter as of March 31, 2025:

Years US MILLIONS
2025(1)
2026 707
2027 647
2028 599
2029 554
Thereafter 5,649
Total amortization expense

All values are in US Dollars.

__________________________

(1)Expected amortization for the remainder of 2025.

Page 40

NOTE 15. INTANGIBLE ASSETS

The components of definite-lived and indefinite-lived intangible assets are as follows. Refer to Note 14 for VOBA asset, which is an actuarial intangible asset arising from a business combination.

March 31, 2025 December 31, 2024
AS OF<br>US$ MILLIONS Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount
Definite-lived intangible assets:
Distributor relationships(1) $ 1,466 $ (57) $ 1,409 $ 1,466 $ (43) $ 1,423
Trade name 71 (11) 60 71 (9) 62
Unpaid claims reserve intangible asset 103 (43) 60 103 (37) 66
Software and other 137 (32) 105 85 (17) 68
Total definite-lived intangible assets 1,777 (143) 1,634 1,725 (106) 1,619
Indefinite-lived intangible assets:
Insurance licenses 71 71 71 71
Total $ 1,848 $ (143) $ 1,705 $ 1,796 $ (106) $ 1,690

__________________________

(1)See Note 16 for the details of the measurement period adjustment to distribution relationships, included within the December 31, 2024 amount, which was recognized upon the Company’s acquisition of AEL in May 2024.

No impairment expenses of intangible assets were recognized for the three months ended March 31, 2025 and 2024. The Company estimates that its intangible assets do not have any significant residual value in determining their amortization. Amortization expenses were $37 million and $12 million for the three months ended March 31, 2025 and 2024, respectively.

The following table outlines the estimated future amortization expense related to definite-lived intangible assets held as of March 31, 2025.

Years US MILLIONS
2025(1)
2026 112
2027 97
2028 87
2029 80
Thereafter 1,168
Total amortization expense

All values are in US Dollars.

__________________________

(1)Expected amortization for the remainder of 2025.

Page 41

NOTE 16. ACQUISITION

Acquisition of American Equity Investment Life Holdings Company in May 2024

On May 2, 2024, the Company, through its subsidiary American National, completed the acquisition of AEL, an Iowa corporation, by acquiring all of AEL’s issued and outstanding common stock not already owned for a total consideration of approximately $4.0 billion comprised of $2.5 billion in cash and $1.1 billion of stock consideration in the form of class A limited voting shares of Brookfield Asset Management Ltd. (“BAM Shares”). The remaining consideration primarily relates to the previously held equity interest in AEL prior to the acquisition as well as the effective settlement of a previously held reinsurance agreement between AEL and NER SPC.

Accounting for the acquisition of AEL is not finalized, and there remains some measurement uncertainty on the acquisition valuation, which is pending completion of a comprehensive evaluation of the net assets acquired, including but not limited to identifiable intangible assets, deferred income tax assets and policyholders’ account balances. The financial statements as of March 31, 2025 reflect management’s current best estimate of the purchase price allocation. Final valuation of the assets acquired and liabilities assumed and the completion of the purchase price allocation will occur by the second quarter of 2025. As a result, the excess of the purchase price over the fair value of net assets acquired, representing goodwill of $662 million as of March 31, 2025 may be adjusted in future periods. Goodwill recognized is not deductible for income tax purposes.

Subsequent to the acquisition, on May 7, 2024, American National completed a downstream merger with AEL and changed its name to American National Group Inc. and reincorporated as a Delaware corporation.

Had the acquisition occurred on January 1, 2023, the consolidated unaudited pro forma revenue and net income would be: (i) $3.9 billion and $1.2 billion, respectively, for the three months ended March 31, 2024; and (ii) $1.8 billion and net loss of $52 million, respectively, for the three months ended March 31, 2023. The pro forma amounts have been calculated using the subsidiary’s results and adjusting them for the revised depreciation and amortization that would have been charged assuming the fair value adjustments to investments, property and equipment and intangible assets had applied from January 1, 2023, together with the consequential tax effects.

Management’s current best estimate of the purchase price allocation reflects the inclusion of updated mortality, base lapse and utilization assumptions related to AEL’s market risk benefits liability as part of its annual assumptions review which took place in the third quarter of 2024. This resulted in a $45 million increase in both the VOBA asset and market risk benefits liability. In addition, discount rate and tax assumptions relating to intangible assets were updated, resulting in a $40 million decrease in intangible assets, $8 million increase to deferred tax asset and a $32 million increase in goodwill.

Page 42

The following summarizes the consideration transferred, fair value of assets acquired and liabilities assumed as of the acquisition date:

US MILLIONS
Fair value of consideration transferred:
Cash
BAM Shares transferred by the Company 1,111
Fair value of the Company’s pre-existing reinsurance agreement effectively settled (541)
Fair value of the Company’s pre-existing interest in AEL 897
Total
Assets acquired:
Investments
Cash and cash equivalents 13,367
Accrued investment income 414
Value of business acquired 9,321
Reinsurance recoverables and deposit assets 6,851
Property and equipment 42
Intangible assets 1,540
Other assets 671
Total assets acquired 75,166
Liabilities assumed:
Future policy benefits 311
Policyholders’ account balances 61,473
Market risk benefits 3,023
Notes payable 768
Subsidiary borrowings 84
Funds withheld for reinsurance liabilities 3,371
Other liabilities 2,093
Total liabilities assumed 71,123
Less: Non-controlling interest 713
Net assets acquired 3,330
Goodwill

All values are in US Dollars.

The Company identified that a reinsurance agreement between AEL and NER SPC constituted a pre-existing relationship in accordance with ASC 805 that would need to be effectively settled as part of the acquisition. The Company recognized an effective settlement loss of $48 million, as a result of derecognizing certain assets and liabilities in relation to the reinsurance agreement, which include deferred policy acquisition costs, deferred sales inducements, reinsurance funds withheld, policyholders’ account balances and market risk benefits liability. The effective settlement loss was included in “Investment related gains (losses)” in the statements of operations in the second quarter of 2024. Concurrently, the Company derecognized NER SPC’s accumulated other comprehensive loss pertaining to market risk benefits liability, recognizing an additional loss of $66 million in “Investment related gains (losses)” in the statements of operations.

The gain on disposal as a result of remeasuring to fair value the pre-existing equity interest in AEL immediately prior to the business combination was approximately $4 million, recognized in “Investment related gains (losses)” in the statements of operations in the second quarter of 2024.

Acquisition-related costs of $127 million incurred were recorded as “Operating expenses” in the statements of operations when incurred in the second quarter of 2024.

Page 43

NOTE 17. FUTURE POLICY BENEFITS

The reconciliation of the balances described in the table below to the “Future policy benefits” in the statements of financial position is as follows.

AS OF<br>US$ MILLIONS March 31, 2025 December 31, 2024
Future policy benefits:
Annuities $ 10,707 $ 10,287
Life Insurance 1,865 1,816
Deferred profit liability:
Annuities 248 242
Life Insurance 83 76
Other contracts and VOBA liability 1,679 1,667
Total future policy benefits $ 14,582 $ 14,088

Page 44

The balances and changes in the liability for future policy benefits are as follows:

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31, 2025<br>US$ MILLIONS Annuities Life Insurance Total
Present value of expected net premiums:
Balance, beginning of period $ $ 2,353 $ 2,353
Beginning balance at original discount rate 2,507 2,507
Effect of changes in cash flow assumptions 61 61
Effect of actual variances from expected experience (2) (34) (36)
Adjusted beginning of period balance (2) 2,534 2,532
Issuances 411 2 413
Interest accrual 3 25 28
Net premiums collected (412) (76) (488)
Ending balance at original discount rate 2,485 2,485
Effect of changes in discount rate assumptions (126) (126)
Balance, end of period $ $ 2,359 $ 2,359
Present value of expected future policy benefits
Balance, beginning of period $ 10,287 $ 4,169 $ 14,456
Beginning balance at original discount rate 10,518 4,601 15,119
Effect of changes in cash flow assumptions(1) 2 71 73
Effect of actual variances from expected experience (30) (37) (67)
Adjusted beginning of period balance 10,490 4,635 15,125
Issuances 412 2 414
Interest accrual 118 45 163
Benefit payments (210) (77) (287)
Derecognitions (lapses and withdrawals) 24 24
Foreign currency translation 23 23
Ending balance at original discount rate 10,857 4,605 15,462
Effect of changes in discount rate assumptions (150) (381) (531)
Balance, end of period $ 10,707 $ 4,224 $ 14,931
Net liability for future policy benefits 10,707 1,865 12,572
Less: Reinsurance recoverables (15) (1,262) (1,277)
Net liability for future policy benefits, after reinsurance recoverable $ 10,692 $ 603 $ 11,295 Weighted average liability duration of future policy benefits (years) 7 15
--- --- --- --- ---
Weighted average interest accretion rate 5 % 5 %
Weighted average current discount rate 5 % 6 %

__________________________

(1)For the three months ended March 31, 2025, the Company recognized liability remeasurement losses of $20 million from the net effect of the changes in cash flow assumptions, which were included in “Policyholder benefits and claims incurred” in the statements of operations.

Page 45

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31, 2024<br>US$ MILLIONS Annuities Life Insurance Total
Present value of expected net premiums
Balance, beginning of period $ $ 3,145 $ 3,145
Beginning balance at original discount rate 3,253 3,253
Effect of changes in cash flow assumptions 62 62
Effect of actual variances from expected experience 2 (15) (13)
Adjusted beginning of period balance 2 3,300 3,302
Issuances 629 17 646
Interest accrual 5 33 38
Net premiums collected (635) (84) (719)
Derecognitions (lapses and withdrawals) (1) (1)
Ending balance at original discount rate 3,266 3,266
Effect of changes in discount rate assumptions 70 70
Balance, end of period $ $ 3,336 $ 3,336
Present value of expected future policy benefits
Balance, beginning of period $ 5,731 $ 5,040 $ 10,771
Beginning balance at original discount rate 5,909 5,277 11,186
Effect of changes in cash flow assumptions(1) 74 74
Effect of actual variances from expected experience 4 (14) (10)
Adjusted beginning of period balance 5,913 5,337 11,250
Issuances 638 17 655
Interest accrual 68 53 121
Benefit payments (161) (79) (240)
Derecognitions (lapses and withdrawals) 1 1
Foreign currency translation (79) (79)
Ending balance at original discount rate 6,380 5,328 11,708
Effect of changes in discount rate assumptions (233) 153 (80)
Balance, end of period $ 6,147 $ 5,481 $ 11,628
Net liability for future policy benefits 6,147 2,145 8,292
Less: Reinsurance recoverables (37) (48) (85)
Net liability for future policy benefits, after reinsurance recoverable $ 6,110 $ 2,097 $ 8,207 Weighted average liability duration of future policy benefits (years) 9 16
--- --- --- --- ---
Weighted average interest accretion rate 5 % 5 %
Weighted average current discount rate 5 % 4 %

__________________________

(1)For the three months ended March 31, 2024, the Company recognized liability remeasurement losses of $12 million from the net effect of the changes in cash flow assumptions, which were included in “Policyholder benefits and claims incurred” in the statements of operations.

Page 46

The amounts of undiscounted and discounted expected gross premiums and future benefit payments follow:

AS OF MAR. 31US MILLIONS 2025 2024
Discounted Undiscounted Discounted
Annuities:
Expected future benefit payments $ 17,999 $ 10,679 $ 10,043 $ 6,159
Expected future gross premiums
Life Insurance:
Expected future benefit payments $ 8,705 $ 4,224 $ 10,411 $ 5,480
Expected future gross premiums 5,587 3,344 7,370 4,487
Total:
Expected future benefit payments $ 26,704 $ 14,903 $ 20,454 $ 11,639
Expected future gross premiums 5,587 3,344 7,370 4,487

All values are in US Dollars.

The amount of revenue and interest recognized in the statements of operations follows:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS Gross Premiums or Assessments Interest Expense
2025 2024 2025 2024
Annuities $ 423 $ 663 $ 116 $ 65
Life Insurance 105 113 20 20

NOTE 18. POLICYHOLDERS’ ACCOUNT BALANCES

Policyholders’ account balances relate to investment-type contracts and universal life-type policies. Investment-type contracts principally include traditional individual fixed rate annuities and fixed index annuities in the accumulation phase and non-variable group annuity contracts.

The reconciliation of the balances described in the table below to the “Policyholders’ account balances” in the statements of financial position is as follows.

AS OF<br>US$ MILLIONS March 31, 2025 December 31, 2024
Policyholders’ account balances:
Annuities $ 81,739 $ 80,046
Life Insurance 2,135 2,107
Embedded derivative adjustments and other(1) 732 926
Total policyholders’ account balances $ 84,606 $ 83,079

__________________________

(1)“Embedded derivative adjustments and other” line reconciles the account balances as presented in the rollforward within this note to the gross liability as presented in the statements of financial position and includes the fair value of the embedded derivatives.

Page 47

The balances and changes in policyholders’ account balances follow.

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31, 2025<br>US$ MILLIONS Annuities Life Insurance Total
Balance, beginning of period $ 80,046 $ 2,107 $ 82,153
Issuances 3,776 14 3,790
Premiums received 31 109 140
Policy charges (131) (83) (214)
Surrenders and withdrawals (2,419) (24) (2,443)
Interest credited 703 12 715
Benefit payments (269) (269)
Other 2 2
Balance, end of period $ 81,739 $ 2,135 $ 83,874 Weighted average crediting rate 3 % 4 %
--- --- --- --- --- --- ---
Net amount at risk(1) $ 12,673 $ 38,851
Cash surrender value $ 74,934 $ 1,870 AS OF AND FOR THE THREE MONTHS ENDED MAR. 31, 2024<br>US$ MILLIONS Annuities Life Insurance Total
--- --- --- --- --- --- ---
Balance, beginning of period $ 22,456 $ 1,975 $ 24,431
Issuances 829 19 848
Premiums received 24 107 131
Policy charges (24) (89) (113)
Surrenders and withdrawals (736) (23) (759)
Interest credited 204 20 224
Benefit payments (14) (14)
Other 7 7
Balance, end of period $ 22,746 $ 2,009 $ 24,755 Weighted average crediting rate 3 % 5 %
--- --- --- --- --- --- ---
Net amount at risk(1) $ 1,368 $ 38,148
Cash surrender value $ 20,783 $ 1,753

__________________________

(1)Net amount at risk is defined as the current guarantee amount in excess of the current account balance.

Page 48

The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums follow.

AS OF MAR. 31, 2025<br>US$ MILLIONS Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum 1 - 50 Basis Points Above 51 - 150 Basis Points Above > 150 Basis Points Above Other(1) Total
Annuities 0% - 1% $ 3,890 $ 2,737 $ 3,913 $ 4,697 $ $ 15,237
1% - 2% 1,598 323 1,109 1,648 4,678
2% - 3% 1,810 394 187 10,421 12,812
Greater than 3% 278 7 3 10 298
Other(1) 48,714 48,714
Total $ 7,576 $ 3,461 $ 5,212 $ 16,776 $ 48,714 $ 81,739
Life Insurance 1% - 2% $ 35 $ 2 $ 63 $ 766 $ $ 866
2% - 3% 390 223 613
Greater than 3% 656 656
Total $ 1,081 $ 2 $ 286 $ 766 $ $ 2,135 AS OF MAR. 31, 2024<br>US$ MILLIONS Range of Guaranteed Minimum Crediting Rate At Guaranteed Minimum 1 - 50 Basis Points Above 51 - 150 Basis Points Above > 150 Basis Points Above Other(1) Total
--- --- --- --- --- --- --- --- --- --- --- --- --- ---
Annuities 0% - 1% $ 2,150 $ 741 $ 688 $ 951 $ $ 4,530
1% - 2% 614 383 1,929 2,001 4,927
2% - 3% 850 374 90 4,955 6,269
Greater than 3% 266 7 1 3 277
Other(1) 6,743 6,743
Total $ 3,880 $ 1,505 $ 2,708 $ 7,910 $ 6,743 $ 22,746
Life Insurance 1% - 2% $ 26 $ 2 $ 140 $ 549 $ $ 717
2% - 3% 418 219 637
Greater than 3% 654 654
Other(1) 1 1
Total $ 1,098 $ 2 $ 359 $ 549 $ 1 $ 2,009

__________________________

(1)Other includes products with either a fixed rate or no guaranteed minimum crediting rate or allocated to index strategies.

Page 49

NOTE 19. MARKET RISK BENEFITS

The net balance of market risk benefit assets and liabilities of, and changes in guaranteed minimum withdrawal benefits associated with, annuity contracts follows.

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Balance, beginning of period $ 2,799 $ 55
Balance, beginning of period, before effect of changes in the instrument-specific credit risk 2,549 39
Issuance 5
Interest accrual 33 3
Attributed fees collected 53 14
Benefits payments
Effect of changes in interest rates 203 (15)
Effect of changes in equity markets 151 10
Effect of changes in equity index volatility (70) (8)
Effect of changes in future expected policyholder behavior 16 (3)
Effect of changes in other future expected assumptions 3 30
Balance, end of period, before the effect of changes in the instrument-specific credit risk 2,943 70
Effect of changes in the ending instrument-specific credit risk 178 54
Balance, end of period 3,121 124
Less: Reinsured MRB, end of period (557)
Balance, end of period, net of reinsurance $ 2,564 $ 124
Net amount at risk(1) $ 12,238 $ 963
Weighted-average attained age of contract holders (years) 71 66

__________________________

(1)Net amount at risk is defined as the current guarantee amount in excess of the current account balance.

The reconciliation of market risk benefits by amounts in an asset position and in a liability position to the “Market risk benefits” amount in the statements of financial position follows.

AS OFUS MILLIONS March 31, 2025 December 31, 2024
Liability Net Asset Liability Net
Market risk benefits $ 945 $ (4,066) $ (3,121) $ 856 $ (3,655) $ (2,799)

All values are in US Dollars.

Page 50

NOTE 20. LIABILITY FOR UNPAID CLAIMS AND CLAIM ADJUSTMENT EXPENSES

The liability for unpaid claims and claim adjustment expenses (“unpaid claims”) for property and casualty insurance is included in “Policy and contract claims” in the statements of financial position and is the amount estimated for incurred but not reported claims (“IBNR”) claims and claims that have been reported but not settled (“case reserves”), as well as associated claim adjustment expenses.

Information regarding the liability for unpaid claims is shown below:

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Policy and contract claims, beginning $ 7,659 $ 7,288
Less: Unpaid claims balance, beginning – long-duration 219 198
Gross unpaid claims balance, beginning – short-duration 7,440 7,090
Less: Reinsurance recoverables, beginning 3,083 3,045
Less: Foreign currency translation 1 4
Net balance, beginning – short-duration 4,356 4,041
Add: incurred related to
Current accident year 438 585
Prior accident years (2) 7
Total incurred claims 436 592
Less: paid claims related to
Current accident year 116 90
Prior accident years 369 402
Total paid claims 485 492
Net unpaid claims balance, ending – short-duration 4,307 4,141
Add: Foreign currency translation 3
Add: Reinsurance recoverables, ending 3,048 3,065
Gross unpaid claims balance, ending – short-duration 7,355 7,209
Add: Unpaid claims balance, ending – long-duration 233 188
Policy and contract claims, ending $ 7,588 $ 7,397

The estimates for ultimate incurred claims attributable to insured events of prior years decreased by $2 million and increased by $7 million, respectively, for the three months ended March 31, 2025 and 2024. The favorable development in the first three months of 2025 was primarily related to lower-than-anticipated losses within certain casualty lines. The unfavorable development in the first three months of 2024 was primarily related to higher-than-anticipated losses within certain run-off lines.

For short-duration health insurance claims, the total of IBNR plus expected development on reported claims included in the liability for unpaid claims as of March 31, 2025 and December 31, 2024 were $7 million and $7 million, respectively.

Page 51

NOTE 21. CORPORATE AND SUBSIDIARY BORROWINGS

Corporate Borrowings

The Company has bilateral revolving credit facilities backed by third-party financial institutions, which bear interest at the specified SOFR, Prime, or bankers’ acceptance rate plus a spread. As of March 31, 2025, the total available amount on the credit facilities was $1.2 billion (December 31, 2024 – $1.2 billion). These credit facilities mature in June 2029. As of March 31, 2025, $342 million was drawn on the bilateral credit facilities (December 31, 2024 – $17 million).

The Company has a $1.0 billion 364-day revolving credit facility, for the purpose of temporarily warehousing investments that will ultimately be transferred into its insurance investment portfolios in the near term. The facility borrowings are generally secured by the underlying investments related to the credit facility drawings. As of March 31, 2025, the facility had $662 million of borrowings outstanding, maturing in October 2025 (December 31, 2024 – $755 million). The Company pledged investments totaling $656 million as collateral as of March 31, 2025, consisting of $271 million of investment funds as well as $385 million of real estate partnerships. As of December 31, 2024, investments totaling $653 million were pledged as collateral consisting of $67 million of private loans, $183 million of investment funds, $19 million of cash and cash equivalents and $384 million of real estate partnerships.

The weighted average interest rates on outstanding corporate borrowings that mature within one year are 6.15% and 6.22% as of March 31, 2025 and December 31, 2024, respectively.

Subsidiary Borrowings

Subsidiary borrowings of $3.3 billion relate to debt issued at ANGI and Argo. $1.8 billion matures in 2027, $600 million matures in 2029, and the remaining $1.0 billion matures between 2032 and 2047. Subsidiary borrowings consist of the following:

•$500 million aggregate principal amount of senior unsecured notes due June 2027 (issued in June 2017), which bear interest at a fixed rate of 5.0%, payable semi-annually;

•$600 million aggregate principal amount of senior unsecured notes due October 2029 (issued in October 2024), which bear interest at a fixed rate of 5.75%, payable semi-annually;

•$500 million aggregate principal amount of senior unsecured notes due June 2032 (issued in June 2022), which bear interest at a fixed rate of 6.14%, payable semi-annually;

•$144 million aggregate principal amount of senior unsecured notes due September 2042 (issued in September 2012), which bear interest at a fixed rate of 6.5%, payable quarterly;

•$1.3 billion principal amount of a term loan maturing in May 2027 (entered into in May 2024), which bear interest tied to SOFR plus a spread, payable quarterly;

•$264 million aggregate principal amount of series of junior subordinated debentures due between May 2033 and September 2037 (issued to its wholly-owned subsidiary trusts that are not consolidated), which bear interest tied to SOFR plus a spread, payable quarterly; and

•$100 million aggregate principal amount of subordinated debentures due June 2047 (issued to its wholly-owned subsidiary trust that is not consolidated), which bear interest at a fixed rate of 5.0%, payable quarterly.

The above noted facilities require the Company and its subsidiaries to maintain minimum net worth covenants. As of March 31, 2025 and December 31, 2024, the Company was in compliance with its financial covenants.

Page 52

The following is the maturity by year on corporate and subsidiary borrowings:

Payments due by year
AS OF MAR. 31, 2025<br>US$ MILLIONS Total Unamortized discount and issuance costs Less than 1 year 1 - 2 years 2 - 3 years 3 - 4 years 4 - 5 years More than 5 years
Corporate borrowings $ 1,004 662 342
Subsidiary borrowings $ 3,332 (76) 1,800 600 1,008 Payments due by year
--- --- --- --- --- --- --- --- --- ---
AS OF DEC. 31, 2024<br>US$ MILLIONS Total Unamortized discount and issuance costs Less than 1 year 1 - 2 years 2 - 3 years 3 - 4 years 4 - 5 years More than 5 years
Corporate borrowings $ 1,022 1,005 17
Subsidiary borrowings $ 3,329 (79) 1,800 600 1,008

Brookfield Credit Agreement

The Company also has a credit facility with Brookfield maturing in June 2025 that, as of March 31, 2025, permitted borrowings of up to $400 million under the Brookfield Credit Agreement. As of March 31, 2025 and December 31, 2024, there were no amounts drawn on the facility.

NOTE 22. INCOME TAXES

For the three months ended March 31, 2025, the effective tax rates on pre-tax income was 23.6% (March 31, 2024 – 6.9%). The Company’s effective tax rate differed from the statutory tax rate of 21.0% (March 31, 2024 – 17.5%) primarily due to international operations subject to different tax rates.

Pillar Two and Bermuda Corporate Income Tax Regime

In December 2023, the Government of Bermuda enacted a corporate income tax (“CIT”) regime, designed to align with the Organization for Economic Cooperation and Development’s (“OECD”) global minimum tax rules. The Corporate Income Tax Act 2023 came into operation in its entirety on January 1, 2025. The regime applies a 15% CIT to Bermuda businesses that are part of Multinational Enterprise (“MNE”) groups with annual revenue of €750 million or more. The Company has deferred tax assets totaling $403 million as of March 31, 2025 relating to this regime (December 31, 2024 – $399 million).

The Company has foreign operating subsidiaries principally located in Bermuda, the U.S., Canada, the Cayman Islands, as well as the U.K. The U.K. enacted legislation in July 2023, implementing certain provisions of Pillar Two. Subsequently on March 21, 2025, the U.K. enacted certain amendments to its Pillar Two legislation, introducing the undertaxed payment rule (“UTPR”) for accounting periods beginning on or after December 31, 2024. Under the amended legislation, the UTPR would be applied as additional top-up tax levied directly on U.K. constituent entities in an amount equal to the UTPR top-up tax allocated to the U.K. There was no material top-up tax allocated to the U.K. as a result of the UTPR for the three months ended March 31, 2025.

On June 20, 2024, Canada enacted new legislation imposing a 15% global minimum tax on profits. The legislation applies retroactively and implements an income inclusion rule and a qualified domestic minimum top-up tax for fiscal years that begin on or after December 31, 2023. As of March 31, 2025, Canada has not enacted legislation addressing the UTPR. The U.S. and the Cayman Islands have not yet passed legislation with respect to Pillar Two.

The Company continues to evaluate the impact of the global minimum tax requirements by monitoring the legislative changes and future developments in relation to Pillar Two across jurisdictions in which the Company operates and assessing their impact on our operations and financial statements. Based on our evaluation of the enacted Pillar Two legislation in Canada and the U.K., we determined that there was no material impact on the effective tax rate for the three months ended March 31, 2025.

Page 53

NOTE 23. SHARE CAPITAL

As of March 31, 2025 and December 31, 2024, the share capital of the Company comprises the following:

AS OFUS MILLIONS, EXCEPT FOR PAR VALUE AND SHARE AMOUNTS March 31, 2025 December 31, 2024
Authorized to Issue Outstanding(1) Carrying Amount Par Value Authorized to Issue Outstanding(1) Carrying Amount
Class A Senior Preferred Shares $ 25.00 100,000,000 $ $ 25.00 100,000,000 $
Class B Senior Preferred Shares C$ 25.00 100,000,000 C$ 25.00 100,000,000
Class A Junior Preferred Shares 25.00 1,000,000,000 25.00 1,000,000,000
Class B Junior Preferred Shares C$ 25.00 1,000,000,000 C$ 25.00 1,000,000,000
Class A Exchangeable Shares 33.01 1,000,000,000 41,371,860 1,436 33.10 1,000,000,000 41,436,516 1,441
Class A-1 Exchangeable Shares 33.01 500,000,000 33.10 500,000,000
Class B Shares 33.01 500,000 24,000 1 33.10 500,000 24,000 1
Class C Shares 1.00 1,000,000,000 201,116,647 8,526 1.00 1,000,000,000 201,116,647 8,526

All values are in US Dollars.

__________________________

(1)The number of issued shares is the same as the number of outstanding shares for all share types, except for Class A exchangeable shares. The number of issued Class A exchangeable shares was 43,449,884 as of March 31, 2025, including 2,078,024 shares held in treasury. The number of issued Class A exchangeable shares as of December 31, 2024 was 43,460,516, including 2,000,000 shares held in treasury.

For the three months ended March 31, 2025, the following event impacted the Company’s share capital position:

•On February 24, 2025, we repurchased 64,656 Class A exchangeable shares, which were held in treasury as of March 31, 2025.

For the three months ended March 31, 2024, other than the conversion of Class A-1 exchangeable shares by certain of its shareholders to Class A exchangeable shares, no other events impacted the Company’s share capital position.

The movement of shares outstanding is as follows:

2025 2024
AS OF AND FOR THE PERIODS ENDED MAR. 31<br><br>SHARE AMOUNTS Class A Exchangeable Shares Class B Shares Class C Shares Class A Redeemable Junior Preferred Shares Class A Exchangeable Shares Class A-1 Exchangeable Shares Class B Shares Class C Shares
Outstanding as of January 1 41,436,516 24,000 201,116,647 100,460,280 15,311,749 28,073,777 24,000 102,056,784
Acquisition of treasury shares, net (64,656)
Conversions 1,523,169 (1,523,169)
Outstanding as of March 31 41,371,860 24,000 201,116,647 100,460,280 16,834,918 26,550,608 24,000 102,056,784

\

Page 54

NOTE 24. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The components of and changes in the accumulated other comprehensive income (“AOCI”), and the related tax effects, are shown below:

AS OF AND FOR THE PERIODS ENDED MAR. 31, 2025<br>US$ MILLIONS Change in Net Unrealized Investment Gains (Losses) Change in Discount Rate for Future Policy Benefits Change in Instrument-Specific Credit Risk for Market Risk Benefit Defined Benefit Pension Plan Adjustment Foreign Currency Translation Total
Balance as of January 1, 2025 $ (12) $ 362 $ (189) $ 104 $ (61) $ 204
Other comprehensive income (loss) before reclassifications 410 (83) 68 (4) 46 437
Amounts reclassified to (from) net income (6) (6)
Deferred income tax benefit (expense) (86) 25 (19) 1 (8) (87)
Balance as of March 31, 2025 $ 306 $ 304 $ (140) $ 101 $ (23) $ 548 AS OF AND FOR THE PERIODS ENDED MAR. 31, 2024<br>US$ MILLIONS Change in Net Unrealized Investment Gains (Losses) Change in Discount Rate for Future Policy Benefits Change in Instrument-Specific Credit Risk for Market Risk Benefit Defined Benefit Pension Plan Adjustment Foreign Currency Translation Total
--- --- --- --- --- --- --- --- --- --- --- --- ---
Balance as of January 1, 2024 $ (438) $ 239 $ (15) $ 85 $ 9 $ (120)
Other comprehensive income (loss) before reclassifications (133) 206 (40) 4 (14) 23
Amounts reclassified to (from) net income (6) (6)
Deferred income tax benefit (expense) 33 (47) 2 (1) (13)
Balance as of March 31, 2024 $ (544) $ 398 $ (53) $ 88 $ (5) $ (116)

Page 55

NOTE 25. EARNINGS PER SHARE

The components of basic earnings per share are summarized in the following table:

FOR THE THREE MONTHS ENDED MAR. 31 <br>US$ MILLIONS, EXCEPT PER SHARE AMOUNTS AND SHARES 2025 2024
Net income (loss) for the period $ (282) $ 337
Dividends on Class A redeemable junior preferred shares(1) (28)
$ (282) $ 309
Attributable to:
Class A exchangeable and Class B shareholders(2) $ 4 $ 3
Class C shareholders (330) 304
Non-controlling interests 44 2
$ (282) $ 309
Earnings per class C share – basic $ (1.64) $ 2.98
Weighted average shares – Class C shares 201,116,647 102,056,784

__________________________

(1)Our Class A redeemable junior preferred shares were converted to Class C shares by Brookfield on December 6, 2024. Accordingly, no dividends were accrued for the three months ended March 31, 2025.

(2)On August 29, 2024, the Company redesignated all of its Class A-1 exchangeable shares into its Class A exchangeable shares. Amounts attributable to Class A exchangeable and Class B shareholders include amounts attributable to Class A-1 exchangeable shareholders prior to the redesignation.

Page 56

NOTE 26. RELATED PARTY TRANSACTIONS

In the normal course of operations, the Company entered into the transactions below with related parties.

(a)Related party transactions under Brookfield agreements

The Company has an outstanding equity commitment in the amount of $2.0 billion from Brookfield to fund future growth, which the Company may draw on from time to time. As of March 31, 2025 and December 31, 2024, there were no amounts drawn under the equity commitment.

The Company has a revolving credit facility with Brookfield under the Brookfield Credit Agreement. Refer to Note 21 for more details.

The following table reflects the related party agreements and transactions involving Brookfield, which includes Brookfield Corporation’s subsidiaries, included in the statements of operations:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Credit agreement fees with Brookfield $ $
Support agreement fees with Brookfield
Rights agreement fees to Brookfield
Administration fees with Brookfield 2 3
Investment management fees to Brookfield(1) 52 20
Licensing agreement fees to Brookfield

__________________________

(1)The Company had $52 million and $20 million of investment management fees payable to Brookfield as of March 31, 2025 and 2024, respectively, which are included in “Due to related parties” on the statements of financial position. The remaining “Due to related parties” balances as of March 31, 2025 and 2024 are primarily related to accounts and loans payable to Brookfield and its subsidiaries.

(b)Other related party transactions

For the three months ended March 31, 2025, the Company and its subsidiaries, in aggregate, purchased related party investments of $290 million (2024 – $125 million). Investment transactions with related parties are accounted for in the same manner as those with unrelated parties in the financial statements.

As of March 31, 2025, we held investments in related parties of $12.6 billion, which include $1.7 billion of our investment in a Brookfield real estate private fund, $1.2 billion of real estate partnerships associated with Brookfield office and retail real estate properties and $949 million of our interest in BBU, to which we apply equity method of accounting (December 31, 2024 – $12.5 billion).

The Company had $312 million of cash on deposit with a wholly-owned subsidiary of Brookfield as of March 31, 2025 (December 31, 2024 – $493 million).

Page 57

NOTE 27. SEGMENT REPORTING

In the second quarter of 2024, as a result of the AEL acquisition, diversification in insurance offerings and overall strategic shift, the Company reorganized and changed its internal segments in a manner that caused the composition of its reporting segments to change. The Company’s reporting segments were realigned to: Annuities, P&C, Life Insurance and Corporate and Other. Previously, the Company reported its operations under the following segments: Direct Insurance, Reinsurance and PRT. The Company has restated all applicable comparative information.

These segments are regularly reviewed by the Company’s chief operating decision maker (“CODM”) for the purpose of allocating resources to the segment and to assess its performance. The Company’s CODM has been identified as the Chief Executive Officer and the Chief Financial Officer.

The key measure used by the CODM in assessing performance and in making resource allocation decisions is Distributable Operating Earnings (“DOE”). DOE provides the CODM with insights on capital allocation and investment strategies, as well as product mix and pricing of insurance products offered by the Annuities, P&C and Life Insurance segments.

DOE is calculated as net income after applicable taxes excluding the impact of depreciation and amortization, deferred income taxes related to basis and other changes, and breakage and transaction costs, as well as certain investment and insurance reserve gains and losses, including gains and losses related to asset and liability matching strategies, non-operating adjustments related to changes in cash flow assumptions for future policy benefits and change in market risk benefits, and is inclusive of returns on equity invested in certain variable interest entities and the Company’s share of adjusted earnings from investments in certain associates. DOE allows the CODM to evaluate the Company’s segments on the basis of return on invested capital generated by its operations and allows the Company to evaluate the performance of its segments.

The tables below provide each segment’s results in the format that the CODM reviews its reporting segments to make decisions and assess performance.

FOR THE THREE MONTHS ENDED MAR. 31, 2025<br>US$ MILLIONS Annuity P&C Life Insurance Corporate & Other Total
Net premiums and other policy related revenues $ 552 $ 648 $ 101 $
Net investment income, including reinsurance funds withheld 1,321 104 51 70
Segment revenues(1)(2) 1,873 752 152 70 $ 2,847
Policyholder benefits, net (531) (436) (85)
Interest sensitive contract benefits, excluding index credits (484) (7)
Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired (222) (110) (7)
Other insurance and reinsurance expenses(3) (92)
Operating expenses excluding transactions costs (122) (88) (21) (29)
Interest expense (80)
Income tax expense, net (96)
Segment DOE $ 422 $ 118 $ 32 $ (135) $ 437
Depreciation and amortization expenses (64)
Deferred income tax recovery relating to basis and other changes 183
Transaction costs (41)
Mark-to-market losses on investments, including reinsurance funds withheld (210)
Mark-to-market losses on insurance contracts and other net assets (587)
Net loss $ (282)

Page 58

FOR THE THREE MONTHS ENDED MAR. 31, 2024<br>US$ MILLIONS Annuities P&C Life Insurance Corporate & Other Total
Net premiums and other policy related revenues $ 652 $ 791 $ 200 $
Net investment income, including reinsurance funds withheld 463 103 111 48
Segment revenues(1)(2) 1,115 894 311 48 $ 2,368
Policyholder benefits, net (679) (540) (187)
Interest sensitive contract benefits, excluding index credits (156)
Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired (27) (188) (10)
Other insurance and reinsurance expenses(3) (23)
Operating expenses excluding transactions costs (75) (65) (57)
Interest expense (72)
Income tax expense (recovery), net (2) (8)
Segment DOE $ 155 $ 99 $ 57 $ (32) $ 279
Depreciation and amortization expenses (22)
Deferred income tax expense relating to basis and other changes (15)
Transaction costs (12)
Mark-to-market gains on investments, including reinsurance funds withheld 183
Mark-to-market losses on insurance contracts and other net assets (76)
Net income $ 337

__________________________

(1)For the three months ended March 31, 2025 and 2024, there were no significant intersegment revenues.

(2)Our consolidated revenues in the statements of operations principally represent the sum of “Segment revenues” and “Mark-to-market gains (losses) on investments, including reinsurance funds withheld” in the tables above.

(3)“Other insurance and reinsurance expenses” primarily represent “Change in fair value of market risk benefits” excluding the effect of changes in market risks (e.g., interest rates, equity markets and equity index volatility) and are inclusive of “Other reinsurance expenses” arising from our reinsurance assumed business on the statements of operations. See Note 19 for the details of market risk benefits and Note 12 for the details of our reinsurance assumed business.

The Company’s Annuities segment offers annuity-based products to individuals and institutions. Total premium revenues recorded within Annuities segment for the three months ended March 31, 2025 and 2024 were primarily from PRT transactions with institutions in the U.S. and Canada. Premiums received from retail annuities are generally recorded as deposits and are not included in net premiums.

Our P&C segment provides a broad range of P&C products through American National and Argo, which include coverage for property, casualty, specialty and other. Total earned premiums within this segment for the three months ended March 31, 2025 and 2024 were primarily from transactions with U.S.-based individuals and institutions.

The Company’s Life Insurance business is principally provided by American National. Total premium revenues recorded within this segment for the three months ended March 31, 2025 and 2024 were primarily from transactions with U.S. retail customers.

Lastly, Corporate and Other segment’s revenue is mainly from investment income earned on investments warehoused by the Company prior to their transfer into its insurance investment portfolios, net of associated borrowing costs.

Page 59

In addition to DOE, the CODM also monitors the assets, including investments accounted for using the equity method, liabilities and equity attributable to each segment.

AS OF MAR. 31, 2025<br>US$ MILLIONS Annuities P&C Life Insurance Corporate & Other Total
Assets $ 113,856 $ 13,589 $ 9,096 $ 5,071 $ 141,612
Liabilities 106,779 8,835 7,897 5,091 128,602
Equity 7,077 4,754 1,199 (20) 13,010 AS OF DEC. 31, 2024<br>US$ MILLIONS Annuities P&C Life Insurance Corporate & Other Total
--- --- --- --- --- --- --- --- --- --- ---
Assets $ 112,931 $ 14,269 $ 7,708 $ 5,045 $ 139,953
Liabilities 105,724 9,574 6,510 5,069 126,877
Equity 7,207 4,695 1,198 (24) 13,076

The following table shows the breakdown of total assets by jurisdiction.

AS OF<br>US$ MILLIONS March 31, 2025 December 31, 2024
United States $ 132,253 $ 130,051
Canada 5,263 5,238
Bermuda 3,432 4,202
Other 664 462
Total assets $ 141,612 $ 139,953

The breakdown of total revenue by jurisdiction follows.

FOR THE THREE MONTHS ENDED MAR. 31 <br>US$ MILLIONS 2025 2024
United States $ 2,517 $ 2,045
Canada 94 116
Bermuda (21) 119
Other(1) 28 205
Total revenue $ 2,618 $ 2,485

__________________________

(1)No other country greater than 10%.

Page 60

NOTE 28. FINANCIAL COMMITMENTS AND CONTINGENCIES

Commitments

As of March 31, 2025, the Company and its subsidiaries, in aggregate, had outstanding commitments to purchase, expand or improve real estate and to fund mortgage loans, private loans and investment funds of $9.7 billion (December 31, 2024 – $10.3 billion).

In addition, the subsidiaries of the Company had outstanding letters of credit in the amount of $37 million as of March 31, 2025 (December 31, 2024 – $437 million).

Federal Home Loan Bank (“FHLB”) Agreements

Certain of the Company’s subsidiaries have access to the FHLB’s financial services including advances that provide an attractive funding source for short-term borrowing and for access to other funding agreements. As of March 31, 2025, certain municipal bonds and collateralized mortgage obligations with a fair value of approximately $688 million (December 31, 2024 – $800 million) and commercial mortgage loans of approximately $624 million (December 31, 2024 – $727 million) were on deposit with the FHLB as collateral for borrowing. As of March 31, 2025, the collateral provided borrowing capacity of approximately $1.1 billion (December 31, 2024 – $881 million). The deposited securities and commercial mortgage loans are included in the statements of financial position within “Available-for-sale fixed maturity securities” and “Mortgage loans on real estate”, respectively.

Litigation

Certain of the Company’s subsidiaries are defendants in various lawsuits concerning alleged breaches of contracts, various employment matters, allegedly deceptive insurance sales and marketing practices, and miscellaneous other causes of action arising in the ordinary course of operations. Certain lawsuits include claims for compensatory and punitive damages. The Company provides accruals for these items to the extent it deems the losses probable and reasonably estimable. After reviewing these matters with legal counsel, based upon information presently available, management is of the opinion that the ultimate resultant liability, if any, would not have a material adverse effect on the statements of financial position, liquidity or results of operations; however, assessing the eventual outcome of litigation necessarily involves forward-looking speculation as to judgments to be made by judges, juries and appellate courts in the future.

Such speculation warrants caution, as the frequency of large damage awards, which bear little or no relation to the economic damages incurred by plaintiffs in some jurisdictions, continues to create the potential for an unpredictable judgment in any given lawsuit. These lawsuits are in various stages of development, and future facts and circumstances could result in management changing its conclusions. It is possible that, if the defenses in these lawsuits are not successful, and the judgments are greater than management can anticipate, the resulting liability could have a material impact on the Company’s financial position, liquidity, or results of operations. With respect to the existing litigation, management currently believes that the possibility of a material judgment adverse to the Company is remote. Accruals for losses are established whenever they are probable and reasonably estimable. If no one estimate within the range of possible losses is more probable than any other, an accrual is recorded based on the lowest amount of the range.

Page 61

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Introduction

This management’s discussion and analysis (“MD&A”) covers the financial position as of March 31, 2025 and December 31, 2024 and the results of operations for the three months ended March 31, 2025 and 2024. Unless the context requires otherwise, when used in this MD&A, the terms “we”, “us”, “our”, or the “Company” mean Brookfield Wealth Solutions Ltd., together with all of its subsidiaries and the term “Brookfield” means Brookfield Corporation, its subsidiaries and controlled companies and any investment fund sponsored, managed or controlled by Brookfield Corporation or its subsidiaries, and does not, for greater certainty, include us or Brookfield Oaktree Holdings, LLC and Oaktree Capital Holdings, LLC and its subsidiaries.

In addition to historical information, this MD&A contains forward-looking statements. Readers are cautioned that these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. See “Forward-Looking Information” within this MD&A.

The information in this MD&A should be read in conjunction with the Unaudited Condensed Consolidated Financial Statements (“the financial statements”) prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as of March 31, 2025 and December 31, 2024 and for the three months ended March 31, 2025 and 2024, as well as the December 31, 2024 audited consolidated financial statements included within the Form 20-F, filed with the SEC on March 27, 2025. Interim operating results for the three months ended March 31, 2025 are not necessarily indicative of the results expected for the entire year.

Overview of Our Business

Our company is an exempted company limited by shares incorporated under the laws of Bermuda on December 10, 2020. The Company holds a direct 100% ownership interest in BAM Re Holdings Ltd. (“BAM Re Holdings”), which holds the Company’s interest in its operating subsidiaries, which are: American National Group Inc. (“ANGI”), Argo Group International Holdings, Inc. (“Argo”), Blumont Annuity Company (“BAC Canada”), Blumont Annuity Company UK Ltd. (“BAC UK”), North End Re Ltd. (“NER Ltd.”) and North End Re (Cayman) SPC (“NER SPC”).

In May 2024, American Equity Investment Life Holdings Company (“AEL”) became a wholly-owned subsidiary of BAM Re Holdings. Following the acquisition of AEL, American National Group, LLC (“American National”) completed a downstream merger with AEL. Subsequently, AEL changed its name to American National Group Inc. Following this merger, American National and AEL generally maintain independent insurance operations while sharing certain corporate and management activities. As such, we continue to make references, where applicable, to the operating results of American National and AEL separately in this MD&A. For further details of the Company’s acquisition of AEL and post-merger reorganization, see Note 16, “Acquisition” in the notes to the financial statements.

Our company is focused on securing the financial futures of individuals and institutions through a range of retirement services, wealth protection products and tailored capital solutions. Our business is presently conducted through our subsidiaries. The principal operating entities of the Company generally maintain their own independent management and infrastructure. Refer to the “Lines of Business” section within this MD&A for further details on our operating segments’ businesses.

As a result of the AEL acquisition, diversification in insurance offerings and overall strategic shift, the Company reorganized and changed its internal segments in a manner that caused the composition of its reporting segments to change in the second quarter of 2024. Our reporting segments have been realigned to: Annuities, Property and Casualty (“P&C”), Life Insurance and Corporate and Other. Previously, we reported our operations under the following segments: Direct Insurance, Reinsurance and Pension Risk Transfer (“PRT”). The Company has restated all applicable comparative information.

Page 62

Controls and Procedures

The Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”) have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2025. Based on the evaluation conducted, it was concluded that our disclosure controls and procedures were effective. There were no changes in the Company’s internal control over financial reporting during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Key Financial Data

The following table presents key financial data of the Company:

AS OF AND FOR THE THREE MONTHS ENDED MAR. 31US MILLIONS 2025 2024
Total assets 141,612 $ 63,113
Net income 337
Distributable Operating Earnings(1) 279

All values are in US Dollars.

__________________________

(1)Distributable Operating Earnings is a Non-GAAP measure. See “Reconciliation of Non-GAAP Measures”.

Page 63

Operating Results and Financial Review

CONSOLIDATED RESULTS OF OPERATIONS

The following table summarizes the financial results of our business for the three months ended March 31, 2025 and 2024:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Net premiums $ 1,122 $ 1,531
Other policy revenue 179 112
Net investment income 1,413 574
Investment related gains (losses) (103) 44
Net investment results from reinsurance funds withheld 7 224
Total revenues 2,618 2,485
Policyholder benefits and claims incurred (1,107) (1,414)
Interest sensitive contract benefits (524) (185)
Amortization of deferred policy acquisition costs, deferred sales inducements and value of business acquired (339) (225)
Change in fair value of insurance-related derivatives and embedded derivatives (200) 44
Change in fair value of market risk benefits (361) (31)
Other reinsurance expenses (1) (7)
Operating expenses (382) (233)
Interest expense (73) (72)
Total benefits and expenses (2,987) (2,123)
Net income (loss) before income taxes (369) 362
Income tax recovery (expense) 87 (25)
Net income (loss) (282) 337
Less: non-controlling interests (44) (2)
Net income (loss) attributable to shareholders $ (326) $ 335

Comparison of three months ended March 31, 2025 and 2024

For the three months ended March 31, 2025, we reported a net loss of $282 million, compared to a net income of $337 million in the prior year quarter. The decrease of $619 million is primarily driven by unfavorable fair value movements in our fixed index annuity reserves due to a decrease in interest rates and equity market performance.

Net premiums and other policy revenue were $1.3 billion for the three months ended March 31, 2025, compared to $1.6 billion in the prior year quarter. The decrease of $342 million is primarily attributable to lower PRT sales in the quarter as compared to the prior year quarter and the phased withdrawal from non-core businesses in our P&C segment.

Net investment income increased by $839 million for the three months ended March 31, 2025, relative to the prior year quarter. Net investment income is comprised of interest and dividends earned on fixed income and equity investments, as well as other miscellaneous income from equity accounted investments primarily consisting of real estate partnerships and investment funds. The increase from the prior year quarter was driven by the growth in our investment portfolio due to the contribution from AEL, coupled with the continued rotation into higher yielding investment strategies.

Investment related gains and losses decreased by $147 million for the three months ended March 31, 2025, relative to the prior year quarter. The decrease is primarily driven by unrealized losses on our equity securities.

Page 64

Net investment results from reinsurance funds withheld decreased by $217 million for the three months ended March 31, 2025 compared to the prior year quarter. The decrease is primarily driven by mark-to-market losses on embedded derivatives arising from our modified coinsurance reinsurance agreement, coupled with reduced investment income from NER SPC, following the deemed settlement of a previously held reinsurance agreement between NER SPC and AEL as part of the AEL acquisition (See Note 16, “Acquisition” in the notes to the financial statements).

Interest sensitive contract benefits represent interest credited to policyholders’ account balances (“PAB”) from our investment contracts with customers, as well as amortization of deferred revenue. For the three months ended March 31, 2025, the amount increased by $339 million due to the assumption of AEL’s PAB liabilities.

Amortization of deferred policy acquisition costs (“DAC”), deferred sales inducements and value of business acquired (“VOBA”) were $339 million for the three months ended March 31, 2025, compared to $225 million in the prior year quarter. The increase of $114 million was primarily driven by the amortization of VOBA arising from the acquisition of AEL.

Change in fair value of insurance-related derivatives and embedded derivatives represents the fair value change of call options used to fund the equity-indexed annuity and universal life contracts as well as the fair value change of embedded derivatives of these contracts. Fair value changes are impacted by the expected and actual performance of the indices the call options relate to as well as interest rates used to estimate our embedded derivatives. The decrease of $244 million is attributable to movements in equity markets and interest rates.

Change in fair value of market risk benefits represents the mark-to-market movements of our liability based on the protection to the policyholder from capital market risks. The loss of $361 million for the three months ended March 31, 2025 is primarily due to movements in interest rates used in the valuation of these liabilities coupled with the assumption of AEL’s market risk benefit liabilities.

Other reinsurance expenses decreased by $6 million. The decrease is due to reduced expenses from our reinsurance assumed businesses as a result of the deemed settlement of a previously held reinsurance agreement between NER SPC and AEL in the second quarter of 2024.

Operating expenses were $382 million for the three months ended March 31, 2025, compared to $233 million in the prior year quarter, which represents an increase of $149 million. The increase was primarily driven by the contribution of expenses from AEL, as well as additional costs incurred to support the continued growth of our business.

Interest expense increased by $1 million for the three months ended March 31, 2025, compared to the prior year quarter. The increase is primarily driven by debt assumed and raised through our acquisition of AEL, partially offset by repayments on our corporate facilities during the period.

Distributable operating earnings (“DOE”) increased by $158 million to $437 million for the three months ended March 31, 2025. The increase was primarily driven by earnings contributions from AEL, coupled with new business wins and higher spread earnings.

Page 65

CONSOLIDATED FINANCIAL POSITION

The following table summarizes the financial position as of March 31, 2025 and December 31, 2024:

AS OF<br><br>US$ MILLIONS Mar. 31, 2025 Dec. 31, 2024
Assets
Investments $ 98,609 $ 92,966
Cash and cash equivalents 8,261 12,243
Accrued investment income 841 860
Deferred policy acquisition costs, deferred sales inducements and value of business acquired 10,848 10,696
Reinsurance funds withheld 1,492 1,517
Premiums due and other receivables 677 647
Ceded unearned premiums 488 520
Deferred tax asset 777 760
Reinsurance recoverables and deposit assets 12,957 13,195
Property and equipment 269 272
Intangible assets 1,705 1,690
Goodwill 783 783
Other assets 2,652 2,461
Separate account assets 1,253 1,343
Total assets 141,612 139,953
Liabilities
Future policy benefits 14,582 14,088
Policyholders’ account balances 84,606 83,079
Policy and contract claims 7,588 7,659
Deposit liabilities 1,483 1,502
Market risk benefits 4,066 3,655
Unearned premium reserve 1,674 1,843
Due to related parties 692 684
Other policyholder funds 357 347
Notes payable 196 189
Corporate borrowings 1,004 1,022
Subsidiary borrowings 3,332 3,329
Funds withheld for reinsurance liabilities 3,266 3,392
Other liabilities 4,503 4,745
Separate account liabilities 1,253 1,343
Total liabilities 128,602 126,877
Equity
Class A exchangeable, Class B and Class C 9,963 9,968
Retained earnings 1,728 2,054
Accumulated other comprehensive income 548 204
Non-controlling interests 771 850
Total equity 13,010 13,076
Total liabilities and equity $ 141,612 $ 139,953

Comparison as of March 31, 2025 and December 31, 2024

Total assets increased by $1.7 billion during the period to $141.6 billion, primarily driven by net annuity inflows coupled with favorable unrealized fair value movements on our fixed maturity investments from a decrease in interest rates during the quarter.

Cash and cash equivalents decreased by $4.0 billion from December 31, 2024 to March 31, 2025 primarily driven by deployment of cash and cash equivalents into short-term investments. We continue to maintain a strong liquidity position across our segments. For further information, refer to “Liquidity and Capital Resources” section within this MD&A.

Page 66

Total investments increased by $5.6 billion from December 31, 2024 to March 31, 2025, primarily driven by the redeployment of cash and cash equivalents into short-term investments, coupled with annuity sales in the quarter.

The decrease in reinsurance funds withheld of $25 million from December 31, 2024 to March 31, 2025 was primarily driven by a decrease in the value of their embedded derivative from reduced interest rates during the quarter.

DAC are capitalized costs directly related to writing new policyholder contracts. The VOBA intangible asset arising from business combinations is also included in this line item. The increase from December 31, 2024 to March 31, 2025 was driven by new business written during the quarter.

Ceded unearned premiums represent a portion of unearned premiums ceded to reinsurers. The decrease of $32 million from December 31, 2024 to March 31, 2025 is primarily driven by the recognition of earned premiums subject to reinsurance.

Reinsurance recoverables and deposit assets are estimated amounts due to the Company from reinsurers or cedants, related to paid and unpaid ceded benefits, claims and expenses and are presented net of reserves for collectability. The decrease of $238 million from December 31, 2024 to March 31, 2025 is driven by a reduction in associated insurance liabilities.

Other assets were $2.7 billion as of March 31, 2025, increasing by $191 million from December 31, 2024. The balance includes current tax assets, market risk benefit asset, prepaid pension assets, as well as other miscellaneous receivables. The increase is primarily driven by the increase in market risk benefit assets.

Intangible assets increased by $15 million from December 31, 2024 to March 31, 2025, principally due to capitalization of costs associated with software and other intangible assets.

Goodwill consists of $662 million arising from the acquisition of AEL in May 2024 as well as $121 million arising from the acquisition of American National in May 2022.

Separate account assets and liabilities both decreased by $90 million from December 31, 2024 to March 31, 2025, principally due to policyholder benefits and withdrawals as well as net realized losses in underlying assets during the quarter.

Future policy benefits and policyholders’ account balances increased by $2.0 billion from December 31, 2024 to March 31, 2025, primarily driven by annuity sales coupled with fair value movements on our embedded derivatives during the period.

Policy and contract claims decreased by $71 million from December 31, 2024 to March 31, 2025 driven by favorable loss experience in our P&C segment during the period.

Corporate and subsidiary borrowings decreased by $15 million from December 31, 2024 to March 31, 2025 primarily driven by repayments on our corporate facilities during the period.

Total equity decreased by $66 million from December 31, 2024 to March 31, 2025. The decrease was primarily driven by a net loss of $282 million recognized during the period coupled with a decrease in non-controlling interests of $79 million, partially offset by $344 million of other comprehensive income arising from favorable unrealized fair value movements on our fixed maturity investments.

Page 67

SEGMENT REVIEW

As a result of the AEL acquisition, diversification in insurance offerings and overall strategic shift, the Company reorganized and changed its internal segments in a manner that caused the composition of its reporting segments to change in the second quarter of 2024. The Company’s reporting segments have been realigned to: Annuities, P&C, Life Insurance and Corporate and Other. Previously, the Company reported its operations under the following segments: Direct Insurance, Reinsurance and PRT.

We measure operating performance primarily using DOE which measures our ability to acquire net insurance assets at a positive margin, and invest these assets at a return that is greater than the cost of policyholder liabilities.

The following table presents DOE of each of our reporting segments for the three months ended March 31, 2025 and 2024:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Annuities $ 422 $ 155
P&C 118 99
Life Insurance 32 57
Corporate and Other (135) (32)
DOE $ 437 $ 279

Comparison of three months ended March 31, 2025 and 2024

Annuities – DOE within our annuities business represents contribution from both our retail and institutional platforms. DOE increased by $267 million for the three months ended March 31, 2025 compared to the prior year quarter. The increase was primarily attributable to earnings contributed from AEL as well as increased investment income from our continued deployment into higher yielding investment strategies.

P&C – DOE increased by $19 million for the three months ended March 31, 2025 compared to the prior year quarter. The increase was primarily driven by improvements in our loss experience arising from underwriting actions implemented over the past twelve months.

Life Insurance – DOE decreased by $25 million for the three months ended March 31, 2025 compared to the prior year quarter. The favorable impact of improved investment income from our continued deployment into higher yielding investment strategies was offset by the ANGI reinsurance agreement executed in the third quarter of 2024, whereby several ANGI subsidiaries ceded a diversified block of life business representing approximately $3.3 billion of insurance liabilities.

Corporate and Other – DOE decreased by $103 million for the three months ended March 31, 2025 compared to the prior year quarter. The decrease was primarily driven by increased interest expenses due to debt assumed and raised through our acquisition of AEL, coupled with increased operating and other expenses incurred to support the continued growth of our business. The prior year quarter included our share of DOE from AEL following the announcement of our acquisition in the third quarter of 2023, which is now presented under the Annuities segment for the current quarter given our acquisition of AEL in May 2024.

Page 68

Lines of Business

Through our operating subsidiaries, our company offers a range of retirement services, wealth protection products and tailored capital solutions focused on securing the financial futures of individuals and institutions.

Annuities

Fixed Index Annuities – Fixed index annuities allow policyholders to earn index credits based on the performance of a particular index without the risk of loss of their account value. Certain products offer a premium bonus in which the initial annuity deposit on these policies is increased at issuance by a specified premium bonus rate. Generally, the surrender charge and bonus vesting provisions of our policies are structured such that we have comparable protection from early termination between bonus and non-bonus products. The annuity contract value is equal to the sum of premiums paid, premium bonuses and interest credited (“index credits” for funds allocated to an index based strategy), which is based upon an overall limit (or “cap”) or a percentage (the “participation rate”) of the appreciation (based in certain situations on monthly averages or monthly point-to-point calculations) in a recognized index or benchmark. Caps and participation rates limit the amount of interest the policyholder may earn in any one contract year and may be adjusted by us annually subject to stated minimums.

Fixed Rate Annuities – Fixed rate deferred annuities include annual, multi-year rate guaranteed products (“MYGAs”) and single premium deferred annuities (“SPDAs”). Our annual reset fixed rate annuities have an annual interest rate (the “crediting rate”) that is guaranteed for the first policy year. After the first policy year, we have the discretionary ability to change the crediting rate once annually to any rate at or above a guaranteed minimum rate. Our MYGAs and SPDAs are similar to our annual reset products except that the initial crediting rate on MYGAs is guaranteed for a stated period of time before it may be changed at our discretion while the initial crediting rate on SPDAs is guaranteed for either three or five years.

Pension Risk Transfer – Pension Risk Transfer is the transfer by a corporate sponsor of the risks, or some of the risks, associated with the sponsorship and administration of a pension plan, in particular, investment risk and longevity risk. Longevity risk represents the risk of an increase in life expectancy of plan beneficiaries. These risks can be transferred either to an insurer like us through a group annuity transaction commonly referred to as PRT, or to an individual through a lump-sum settlement payment. PRT using insurance typically involves a single premium group annuity contract that is issued to a pension plan by an insurer, permitting the corporate pension plan sponsor to discharge certain pension plan liabilities from its balance sheet.

Funding Agreements – Funding agreements are issued by certain of our insurance subsidiaries to special-purpose unaffiliated trusts in connection with our funding agreement-backed notes (“FABN”) program.

Single Premium Immediate Annuities – A single premium immediate annuity is purchased with one premium payment, providing periodic (usually monthly or annual) payments to the annuitant for a specified period, such as for the remainder of the annuitant’s life. Return of the original deposit may or may not be guaranteed, depending on the terms of the annuity contract.

Variable Annuities – With a variable annuity, the policyholder bears the investment risk because the value of the policyholder’s account balance varies with the investment experience of the separate account investment options selected by the policyholder. Our variable annuity products have no guaranteed minimum withdrawal benefits. This product accounts for less than 1% of our annuities business.

Property and Casualty

Property – Property lines offer policies protecting various personal and commercial properties from man-made and natural disasters, including property insurance for homeowners and renters.

Casualty – Casualty lines include a broad range of primary and excess casualty products, such as specialty casualty, construction defect, general liability, commercial multi-peril, workers compensation, product liability, environmental liability and auto liability. Casualty lines are generally considered long-tailed as it takes a relatively long period of time to finalize and resolve all claims from a given accident year. Some products have long claims reporting lags and/or longer time lags for payment of claims.

Specialty – Specialty lines include niche insurance coverages such as garage and inland marine and offer insurance programs and fronting solutions. Specialty lines are considered generally short-tailed as claims are typically known relatively quickly, although it may take a longer period of time to finalize and resolve all claims from a given year.

Page 69

Run-off and Other – Run-off and Other lines primarily consist of discontinued lines previously underwritten by our insurance subsidiaries including professional liability and surety coverages.

Life Insurance

Whole Life – Whole life products provide a guaranteed benefit upon the death of the insured in return for the periodic payment of a fixed premium over a predetermined period. Premium payments may be required for the entire life of the contract, to a specified age or a fixed number of years, and may be level or change in accordance with a predetermined schedule. Whole life insurance includes some policies that provide a participation feature in the form of dividends. Policyholders may receive dividends in cash or apply them to increase death benefits or cash values available upon surrender, or reduce the premiums required to maintain the contract in-force.

Universal Life – Universal life insurance products provide coverage through a contract that gives the policyholder flexibility in premium payments and coverage amounts. Universal life products may allow the policyholder, within certain limits, to increase or decrease the amount of death benefit coverage over the term of the contract and to adjust the frequency and amount of premium payments. Universal life products are interest rate sensitive, and we determine the interest crediting rates during the contract period, subject to policy specific minimums. An equity-indexed universal life product is credited with interest using a return that is based, in part, on changes in an index, such as the Standard & Poor’s 500 Index (“S&P 500”), subject to a specified minimum.

Variable Universal Life – Variable universal life products provide insurance coverage on a similar basis as universal life, except that the policyholder bears the investment risk because the value of the policyholder’s account balance varies with the investment experience of the securities selected by the policyholder held in the separate account.

Corporate and Other

Our Corporate and Other segment performs various corporate and other activities that support our core insurance operations. Such activities include our investment warehousing activities where we temporarily warehouse investments that will ultimately be transferred into our insurance investment portfolios in the near term. We generate investment income from warehoused investments and incur interest expenses on revolving credit facilities utilized to fund these investments. Also included in our Corporate and Other segment activities are certain hedging activities, certain charges and activities that are not attributable to our insurance operating segments and interest expense related to the Company’s corporate and subsidiary borrowings.

Page 70

Net Premiums

The breakdown of premiums by product, net of ceded premiums, is as follows:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Annuities
Retail(1):
Fixed Index $ $
Fixed Rate 2 2
Variable
Total Retail Annuities 2 2
Institutional:
Pension Risk Transfer(2) 400 612
Funding Agreements(1)
Total Institutional Annuities 400 612
Total Annuities 402 614
Whole Life and Others 80 132
Property and Casualty
Property 71 91
Casualty 504 516
Specialty 61 67
Run-off and Other 4 111
Total Property and Casualty 640 785
Total Net Premiums $ 1,122 $ 1,531

__________________________

(1)Premiums received from retail annuities and funding agreements are generally recorded as deposits and are not included in net premiums.

(2)Premiums differ from gross annuity sales in PRT, since premiums are recognized as revenue when due while they are included in sales upon deal close, which is confirmed by the counterparty.

Comparison of the three months ended March 31, 2025 and 2024

For the three months ended March 31, 2025, we reported total net premiums of $1.1 billion, compared to $1.5 billion in the prior year quarter. The decrease of $409 million is primarily due to the phased withdrawal from non-core businesses in our P&C segment, reinsurance agreements executed in our Life Insurance segment and seasonality in our PRT business.

Page 71

Gross Annuity Sales

Gross annuity sales are comprised of all products’ deposits, which generally are not included in revenues on the statement of operations. Gross annuity sales include directly written business, flow reinsurance assumed as well as premiums and deposits generated from assumed block reinsurance transactions.

The breakdown of gross annuity sales follows:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Retail:
Fixed Index $ 1,835 $ 188
Fixed Rate 1,049 702
Variable 46 16
Total Retail Annuities 2,930 906
Institutional:
Pension Risk Transfer(1) 408 776
Funding Agreements 500
Total Institutional Annuities 908 776
Total Gross Annuity Sales $ 3,838 $ 1,682

__________________________

(1)Gross annuity sales differ from premiums in PRT, since premiums are recognized as revenue when due while they are included in sales upon deal close, which is confirmed by the counterparty.

Comparison of the three months ended March 31, 2025 and 2024

For the three months ended March 31, 2025, we reported total gross annuity sales of $3.8 billion, compared to $1.7 billion in the prior year quarter. The increase of $2.2 billion is primarily due to the contribution from AEL coupled with our FABN issuance during the quarter.

Liquidity and Capital Resources

CAPITAL RESOURCES

We strive to maintain sufficient financial liquidity at all times so that we are able to participate in attractive opportunities as they arise, better withstand sudden adverse changes in economic circumstances within our operating subsidiaries and maintain payments to policyholders, as well as maintain distributions to our shareholders. Our principal sources of liquidity are cash flows from our operations, access to the Company’s third-party credit facilities, and our credit facility and equity commitment with Brookfield. We proactively manage our liquidity position to meet liquidity needs and continue to develop relationships with lenders who provide borrowing capacity at competitive rates, while looking to minimize adverse impacts on investment returns. We look to structure the ownership of our assets to enhance our ability to monetize them to provide additional liquidity, if needed. Our corporate liquidity for the periods noted below consisted of the following:

AS OF<br>US$ MILLIONS Mar. 31, 2025 Dec. 31, 2024
Cash and cash equivalents $ 93 $ 311
Liquid financial assets 116
Undrawn credit facilities 1,621 1,608
Total Corporate Liquidity(1) $ 1,714 $ 2,035

__________________________

(1)Total Corporate Liquidity is a Non-GAAP measure. See “Performance Measures used by Management”.

Page 72

As of the date of this MD&A, our liquidity is sufficient to meet our present requirements for the foreseeable future. In June 2021, Brookfield provided to the Company an equity commitment in the amount of $2.0 billion to fund future growth, which the Company may draw on from time to time. The equity commitment may be called by the Company in exchange for the issuance of Class C shares or redeemable junior preferred shares. As of March 31, 2025, there was $2.0 billion of undrawn equity commitment available. In addition, in connection with the Company’s spin-off from Brookfield on June 28, 2021, we entered into a credit agreement with Brookfield as the lender, providing a revolving $400 million credit facility. We have $1.2 billion of revolving bilateral credit facilities with external banks. We use the liquidity provided by our credit facilities for working capital purposes, and we may use the proceeds from the capital commitment to fund growth capital investments and acquisitions. The determination of which of these sources of funding the Company will access in any particular situation is a matter of optimizing needs and opportunities at that time. As of March 31, 2025, there was $342 million drawn on the external bilateral facilities and no amount drawn on the Brookfield facility.

Today, we have significant liquidity within our insurance portfolios, giving us flexibility to secure attractive investment opportunities. In addition to a portfolio of highly liquid financial assets, our operating companies have additional access to liquidity from sources such as the Federal Home Loan Bank (“FHLB”) programs. As of March 31, 2025, the Company had no drawings and a total of $1.1 billion undrawn commitment available related to these programs.

Liquidity within our operating subsidiaries may be restricted from time to time due to regulatory constraints. As of March 31, 2025, the Company’s total liquidity was $48.4 billion, which included $93 million of unrestricted cash and cash equivalents held by non-regulated corporate entities.

AS OF<br>US$ MILLIONS Mar. 31, 2025 Dec. 31, 2024
Cash and cash equivalents $ 8,261 $ 12,243
Liquid financial assets 38,510 39,195
Undrawn credit facilities 1,621 1,608
Total Liquidity(1) $ 48,392 $ 53,046

__________________________

(1)Total Liquidity is a Non-GAAP measure. See “Performance Measures used by Management”.

As of March 31, 2025 and December 31, 2024, 87% and 87% of the Company’s Total Liquidity was held by our U.S. insurance subsidiaries, respectively.

In addition to the total corporate liquidity and total liquidity, we maintain a strong capital position across our regulated insurance subsidiaries and holding companies to fulfill our commitment to the policyholders and retirees we serve. Our capital position underpins the A financial strength ratings assigned to our life and annuity companies and the investment grade ratings for our life and annuity holding companies.

Comparison of the three months ended March 31, 2025 and 2024

The following table presents a summary of our cash flows and ending cash balances for the three months ended March 31, 2025 and 2024:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Operating activities $ 529 $ 232
Investing activities (5,569) (2,293)
Financing activities 1,054 333
Cash and cash equivalents:
Cash and cash equivalents, beginning of period 12,243 4,308
Net change during the period (3,986) (1,728)
Foreign exchange on cash balances held in foreign currencies 4 (6)
Cash and cash equivalents, end of period $ 8,261 $ 2,574

Page 73

Operating Activities

For the three months ended March 31, 2025, we generated $529 million of cash from operating activities compared to $232 million generated during the prior year. The increase is primarily due to higher investment income from the growth in the investment portfolio as well as the contributions from AEL.

Investing Activities

During the current period, $5.6 billion of cash outflows from investing activities arose as we deployed cash and cash equivalents held as of December 31, 2024 to short-term investments and continue to rotate our investment portfolio into higher yielding investment strategies, compared to a net deployment of $2.3 billion in the prior year period.

Financing Activities

For the three months ended March 31, 2025, we had a net cash inflow of $1.1 billion, which increased from a net cash inflow of $333 million in the prior year period. The increase was primarily driven by deposits received on policyholders’ accounts, partially offset by withdrawals on such accounts.

Financial Instruments

To the extent that we believe it is economic to do so, our strategy is to hedge a portion of our equity investments and/or cash flows exposed to foreign currencies by the Company. The following key principles form the basis of our foreign currency hedging strategy:

•We leverage any natural hedges that may exist within our operations;

•We utilize local currency debt financing to the extent possible; and

•We may utilize derivative contracts to the extent that natural hedges are insufficient.

As of March 31, 2025, our total equity was $13.0 billion. Included in equity was approximately $209 million and $128 million invested in Canadian dollars and British pounds, respectively. As of March 31, 2025, we had a notional $3.9 billion (December 31, 2024 – $5.3 billion) of foreign exchange forward and cross currency forward contracts in place to hedge against foreign currency risk.

For additional information, see Note 9, “Derivative Instruments” in the notes to the financial statements.

Future Capital Obligations and Requirements

As of March 31, 2025, the Company and its subsidiaries, in aggregate, had total unfunded investment commitments of $9.7 billion (December 31, 2024 – $10.3 billion). These commitments, when funded, are primarily recognized as mortgage loans, private loans, investment funds, investment real estate and other invested assets. For additional information, see Note 28, “Financial Commitments and Contingencies” in the notes to the financial statements.

The following is the maturity by year on corporate and subsidiary borrowings:

Payments due by year
AS OF MAR. 31, 2025<br>US$ MILLIONS Total Unamortized discount and issuance costs Less than 1 year 1 - 2 years 2 - 3 years 3 - 4 years 4 - 5 years More than 5 years
Corporate borrowings $ 1,004 662 342
Subsidiary borrowings $ 3,332 (76) 1,800 600 1,008 Payments due by year
--- --- --- --- --- --- --- --- --- ---
AS OF DEC. 31, 2024<br><br>US$ MILLIONS Total Unamortized discount and issuance costs Less than 1 year 1 - 2 years 2 - 3 years 3 - 4 years 4 - 5 years More than 5 years
Corporate borrowings $ 1,022 1,005 17
Subsidiary borrowings $ 3,329 (79) 1,800 600 1,008

For additional information, see Note 21, “Corporate and Subsidiary Borrowings” in the notes to the financial statements.

Page 74

Capital Management

Capital management is the ongoing process of determining and maintaining the quantity and quality of capital appropriate to take advantage of the Company’s growth opportunities, to support the risks associated with the business and to optimize shareholder returns while fully complying with the regulatory capital requirements.

The Company and its subsidiaries take an integrated approach to risk management that involves the Company’s risk appetite and capital requirements. The operating capital levels are determined by each respective operating company’s risk appetite and Own Risk and Solvency Assessment (“ORSA”). Furthermore, additional stress techniques are used to evaluate the Company’s capital adequacy under sustained adverse scenarios.

American National, AEL and certain Argo subsidiaries are required to follow Risk Based Capital (“RBC”) requirements based on guidelines of the National Association of Insurance Commissioners (“NAIC”). RBC is a method of measuring the level of capital appropriate for an insurance company to support its overall business operations, in light of its size and risk profile. It provides a means of assessing capital adequacy, where the degree of risk taken by the insurer is the primary determinant.

Freestone Re Ltd., Argo Re Ltd. and NER Ltd. are required to maintain minimum statutory capital and surplus equal to the minimum solvency margin and the minimum economic capital and surplus equal to the enhanced capital requirement as determined by the Bermuda Monetary Authority (“BMA”). The Enhanced Capital Requirement (“ECR”) is calculated based on the Bermuda Solvency Capital Requirement model, a risk-based model that takes into account the risk characteristics of different aspects of a company’s business.

BAC Canada is subject to Life Insurance Capital Adequacy Test (“LICAT”) as determined by Office of the Superintendent of Financial Institutions (“OSFI”). The LICAT ratio compares the regulatory capital resources of an insurance company to its Base Solvency Buffer or required capital.

BAC UK is subject to the assessment of its capital adequacy under a prudential regulatory framework known as Solvency UK determined by the Prudential Regulatory Authority (“PRA”), which is a new framework introduced to replace the European Union’s Solvency II regime, effective December 31, 2024.

The Company has determined that it is in compliance with all capital requirements as of March 31, 2025 and December 31, 2024.

Page 75

Brookfield Operating Results

An investment in the Class A exchangeable shares of the Company is intended to be, as nearly as practicable, functionally and economically, equivalent to an investment in Brookfield. A summary of Brookfield’s operating results for the three months ended March 31, 2025 and 2024 and is provided below:

FOR THE THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS, EXCEPT PER SHARE AMOUNTS 2025 2024
Revenues $ 17,944 $ 22,907
Net income attributable to Brookfield shareholders 73 102
Net income of consolidated business 215 519
Net income per share:
Basic 0.02 0.04
Diluted 0.02 0.04
Distributable earnings before realizations 1,301 1,001

For the three months ended March 31, 2025 and 2024, Brookfield’s pro rata share of our DOE represented approximately 33% and 27% of their total distributable earnings before realizations, respectively.

Each exchangeable share has been structured with the intention of providing an economic return equivalent to one Brookfield Class A Share due to each exchangeable share (i) being exchangeable at the option of the holder for one Brookfield Class A Share or its cash equivalent (the form of payment to be determined at the election of Brookfield), subject to certain limitations, and (ii) receiving distributions at the same time and in the same amounts as dividends on the Brookfield Class A Shares. We therefore expect that the market price of the exchangeable shares should be impacted by the market price of Brookfield Class A Shares and the business performance of Brookfield as a whole. In addition to carefully considering the disclosure made in this MD&A, carefully consideration should be made to the disclosure made by Brookfield in its continuous disclosure filings. Copies of the Brookfield’s continuous disclosure filings are available electronically on EDGAR on the SEC’s website at www.sec.gov or on SEDAR+ at www.sedarplus.com.

Industry Trends and Factors Affecting Our Performance

As a financial services business providing capital based solutions to the insurance industry, we are affected by numerous factors, including global economic and financial market conditions. Price fluctuations within equity, credit, commodity and foreign exchange markets, as well as interest rates, which may be volatile and mixed across geographies, can significantly impact the performance of our business. We also monitor factors such as consumer spending, business investment, the volatility of capital markets, interest rates, unemployment and the risk of inflation or deflation, which affect the business and economic environment and, in turn, impact the demand for the type of financial and insurance products offered by our business. Refer to “Industry Trends and Factors Affecting Our Performance” included in the MD&A of our most recent annual report of Form 20-F.

Critical Accounting Policies and Estimates

The preparation of the financial statements requires management to make critical judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses that are not readily apparent from other sources, during the reporting period. These estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the year in which the estimate is revised if the revision affects only that year or in the year of the revision and future years if the revision affects both current and future years. Refer to “Critical Accounting Policy and Estimates” included in the MD&A of our most recent annual report of Form 20-F.

Page 76

Performance Measures Used by Management

To measure performance, we focus on net income and total assets, as well as certain Non-GAAP measures, including DOE, Net Investment Income including Reinsurance Funds Withheld, Cost of Funds, Total Corporate Liquidity and Total Liquidity which we believe are useful to investors to provide additional insights into assets within the business available for redeployment. Refer to the “Segment Review” and “Liquidity and Capital Resources” sections of this MD&A for further discussion on our performance and Non-GAAP measures for the three months ended March 31, 2025 and 2024.

Non-GAAP Measures

We regularly monitor certain Non-GAAP measures that are used to evaluate our performance and analyze underlying business performance and trends. We use these measures to establish budgets and operational goals, manage our business and evaluate our performance. We also believe that these measures help investors compare our operating performance with our results in prior years. These Non-GAAP financial measures are provided as supplemental information to the financial measures presented in this MD&A that are calculated and presented in accordance with GAAP. These Non-GAAP measures are not comparable to GAAP and may not be comparable to similarly described Non-GAAP measures reported by other companies, including those within our industry. Consequently, our Non-GAAP measures should not be evaluated in isolation, but rather, should be considered together with the most directly comparable GAAP measure in our financial statements for the periods presented. The Non-GAAP financial measures we present in this MD&A should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.

Distributable Operating Earnings

We use DOE to assess operating results and the performance of our businesses. We define DOE as net income after applicable taxes excluding the impact of depreciation and amortization, deferred income taxes related to basis and other changes, and breakage and transaction costs, as well as certain investment and insurance reserve gains and losses, including gains and losses related to asset and liability matching strategies, non-operating adjustments related to changes in cash flow assumptions for future policy benefits and change in market risk benefits, and is inclusive of returns on equity invested in certain variable interest entities and our share of adjusted earnings from our investments in certain associates.

DOE is a measure of operating performance that is not calculated in accordance with, and does not have any standardized meaning prescribed by GAAP. DOE is therefore unlikely to be comparable to similar measures presented by other issuers.

We believe our presentation of DOE is useful to investors because it supplements investors’ understanding of our operating performance by providing information regarding our ongoing performance that excludes items we believe do not directly affect our core operations. Our presentation of DOE also provide investors enhanced comparability of our ongoing performance across years.

Net investment income, including reinsurance funds withheld and Cost of funds form part of DOE and represent net investment income inclusive of certain investment gains and losses and expenses directly attributable to our core insurance operations, respectively, that are not otherwise excluded from DOE.

Total Corporate Liquidity and Total Liquidity

Corporate Liquidity is a measure of our liquidity position and includes cash and cash equivalents, undrawn revolving credit facilities and liquid financial assets held by non-regulated corporate entities. Total Liquidity includes liquidity within our regulated insurance entities.

Page 77

The followings contain further details regarding our use of the Non-GAAP measures, as well as a reconciliation of GAAP consolidated net income and total equity to these measures:

Reconciliation of Non-GAAP Measures

The following table reconciles our net income to DOE:

FOR THREE MONTHS ENDED MAR. 31<br>US$ MILLIONS 2025 2024
Net income (loss) $ (282) $ 337
Mark-to-market losses (gains) on investments, including reinsurance funds withheld(1) 210 (183)
Mark-to-market losses (gains) on insurance contracts and other net assets(2)(3) 587 76
Deferred income tax expense (recovery) relating to basis and other changes (183) 15
Transaction costs 41 12
Depreciation and amortization expenses 64 22
DOE $ 437 $ 279

__________________________

(1)“Mark-to-market losses (gains) on investments, including reinsurance funds withheld” primarily represent mark-to-market gains or losses on our investments and reinsurance funds withheld. Mark-to-market gains or losses on our investments are presented as “Investment related gains (losses)” on the statements of operations. See Note 10, “Net Investment Income and Investment Related Gains (Losses)” in the notes to the financial statements for additional details. Mark-to-market gains or losses on reinsurance funds withheld are included in “Net investment results from reinsurance funds withheld” and represent the change in fair value of their embedded derivative during the period. See Note 9, “Derivative Instruments” in the notes to the financial statements for additional details.

(2)“Mark-to-market losses (gains) on insurance contracts and other net assets” principally represents the mark-to-market effect on insurance-related liabilities, net of reinsurance, due to changes in market risks (e.g., interest rates, equity markets and equity index volatility). These mark-to-market effects are primarily included in “Interest sensitive contract benefits”, “Change in fair value of insurance-related derivatives and embedded derivatives” and “Change in fair value of market risk benefits” on the statements of operations. See the following notes to the financial statements for additional information: (i) Note 9, “Derivative Instruments”; (ii) Note 18, “Policyholders’ Account Balances”; and (iii) Note 19, “Market Risk Benefits”.

(3)Included in “Mark-to-market losses (gains) on insurance contracts and other net assets” are “returns on equity invested in certain variable interest entities” and “our share of adjusted earnings from our investments in certain associates” as stated in the definition of DOE. “Returns on equity invested in certain variable interest entities” primarily represent equity-accounted income from our investments in real estate partnerships and investment funds and are included in “Net investment income” on the statements of operations. Additionally, “our share of adjusted earnings from our investments in certain associates” represents our share of DOE from AEL following the announcement of our acquisition in the third quarter of 2023, which is no longer applicable given our acquisition of AEL in May 2024.

Page 78

Forward-Looking Information

In addition to historical information, this MD&A contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may relate to the Company and Brookfield’s outlook and anticipated events or results and may include information regarding the financial position, business strategy, growth strategy, budgets, operations, financial results, taxes, dividends, distributions, plans and objectives of the Company. Particularly, information regarding future results, performance, achievements, prospects or opportunities of the Company, Brookfield’s or the Canadian, U.S. or international markets is forward-looking information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”.

The forward-looking statements are based on our beliefs, assumptions and expectations of future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

We caution that the factors that could cause our actual results to vary from our forward-looking statements described in this MD&A are not exhaustive. The forward-looking statements represent our views as of the date of this MD&A and should not be relied upon as representing our views as of any date subsequent to the date of this MD&A. While we anticipate that subsequent events and developments may cause our views to change, we disclaim any obligation to update the forward-looking statements, other than as required by applicable law. For further information on these known and unknown risks, please see “Risk Factors” included in our most recent annual report of Form 20-F and other risks and factors that are described therein.

Page 79

Document

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549

Form 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

For the month of: May 2025 Commission File Number: 001-40509

BROOKFIELD WEALTH SOLUTIONS LTD. (Name of Registrant)

Ideation House, First Floor

94 Pitts Bay Road, Pembroke, HM08, Bermuda (Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F Form 40-F

The information contained in Exhibit 99.1 of this Form 6-K is incorporated by reference into the registrant’s registration statement on Form F-3 (File No. 333-276533).

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Exhibit Index

Exhibit Description of Exhibit
99.1 Brookfield Wealth Solutions Ltd.’s interim report for the quarter ended March 31, 2025
99.2 Certification of Sachin Shah, Chief Executive Officer, Brookfield Wealth Solutions Ltd., pursuant to Canadian law
99.3 Certification of Thomas Corbett, Chief Financial Officer, Brookfield Wealth Solutions Ltd., pursuant to Canadian law
  • 3 -

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BROOKFIELD WEALTH SOLUTIONS LTD.
Date: May 12, 2025 By: /s/ Thomas Corbett
Name:    Thomas Corbett<br>Title:       Chief Financial Officer

Document

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS

FULL CERTIFICATE

I, Sachin Shah, Chief Executive Officer, Brookfield Wealth Solutions Ltd., certify the following:

1,Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Brookfield Wealth Solution Ltd. (the “issuer”) for the interim period ended March 31, 2025.

2,No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

3,Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

4,Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

5,Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings

(a)designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

i.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

ii.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

(b)designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

5.1Control framework: The control framework the issuer’s other certifying officer and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) published by The Committee of Sponsoring Organizations of the Treadway Commission (COSO).

5.2ICFR – material weakness relating to design: N/A

5.3Limitation on Scope of Design: N/A

6,Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning January 1, 2025 and ended on March 31, 2025 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

Date: May 12, 2025<br><br><br><br>/s/ Sachin Shah
Sachin Shah <br>Chief Executive Officer

Document

FORM 52-109F2

CERTIFICATION OF INTERIM FILINGS

FULL CERTIFICATE

I, Thomas Corbett, Chief Financial Officer, Brookfield Wealth Solutions Ltd., certify the following:

1,Review: I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Brookfield Wealth Solutions Ltd. (the “issuer”) for the interim period ended March 31, 2025.

2,No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

3,Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

4,Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

5,Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings

(a)designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

i.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

ii.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

(b)designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

5.1Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Internal Control – Integrated Framework (2013) published by The Committee of Sponsoring Organizations of the Treadway Commission (COSO).

5.2ICFR – material weakness relating to design: N/A

5.3Limitation on Scope of Design: N/A

6,Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning January 1, 2025 and ended on March 31, 2025 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

Date: May 12, 2025<br><br><br><br>/s/ Thomas Corbett
Thomas Corbett<br>Chief Financial Officer